Malignant neoplasm of eye, brain and central nervous system, including Hilmo

C3_EYE_BRAIN_NEURO_WIDE

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	557745
1. Apply sex-specific rule None	557745
2. Check conditions None	557745
3. Check pre-conditions, main-only, mode, registry filters None 0 out of 7 registries used, show all original rules.	0
4. Check minimum number of events None	0
5. Include endpoints C3_EYE_ADNEXA_WIDE C3_MENINGES_WIDE C3_BRAIN_WIDE C3_SPINAL_CORD_CRANIAL_AND_OTHER_CNS_WIDE	3344
6. Filter based on genotype QC (FinnGen only)	2986

Control definitions (FinnGen only)

Control exclude: C3_CANCER, C3_CANCER_WIDE

Extra metadata

Level in the ICD hierarchy: 2
First used in FinnGen datafreeze: DF14

NAME	C3_EYE_BRAIN_NEURO_WIDE
CONTROL_EXCLUDE	C3_CANCER\|C3_CANCER_WIDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE	C3_EYE_ADNEXA_WIDE\|C3_MENINGES_WIDE\|C3_BRAIN_WIDE\|C3_SPINAL_CORD_CRANIAL_AND_OTHER_CNS_WIDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Malignant neoplasm of eye, brain and central nervous system, including Hilmo based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

No data for upset plot.

No data for upset table.

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded (different definition than used in FinnGen).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	2986	1391	1595
Unadjusted period prevalence (%)	0.62	0.49	0.73
Median age at first event (years)	60.39	57.48	62.92

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
3099: Matched controls
30983

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

YA1AD

NOMESCO Finland

CT examination of head and neck for dose design of radiotherapy

495.6

319.9

314

WD105

NOMESCO Finland

Cystostatic therapy of methastized malignancy

673.7

313.5

305

D43.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Brain, supratentorial

351.2

307.7

573

111

Kela drug reimbursment

Epilepsy and comparable convulsive disorders

17.8

307.7

956

759

XX3DW

NOMESCO Finland

Time consuming IT work

14.4

307.7

693

609

A04AA01

ATC

ondansetron; systemic, rectal

20.3

307.7

606

366

N03AX14

ATC

levetiracetam; systemic

38.2

307.7

870

313

AAG50

NOMESCO Finland

Stereotactic intracranial radiotherapy

385.5

307.7

343

ZXC95

NOMESCO Finland

Use of surgical navigator

42.1

307.7

439

121

Z51.5

ICD-10 Finland

Palliative care

17.8

307.7

762

557

N03AX18

ATC

lacosamide; systemic

41.7

307.7

250

AAB00

NOMESCO Finland

Extirpation of intracranial lesion

35.9

307.7

346

108

A03FA01

ATC

metoclopramide; systemic, rectal

10.5

307.7

1298

1984

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

20.8

307.7

1362

1126

WF002

NOMESCO Finland

Radical radiotherapy

441.8

307.7

688

ZXC40

NOMESCO Finland

Use of ultrasound

60.0

307.7

181

N03AF02

ATC

oxcarbazepine; oral

11.1

307.7

415

426

L01AX03

ATC

temozolomide; systemic

+∞

307.7

866

D43.9

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Central nervous system, unspecified

169.5

307.7

176

WB103

NOMESCO Finland

Simple adjuvant cytostatic therapy

1855.8

307.7

322

H02AB02

ATC

dexamethasone; systemic

213.8

307.7

1635

161

130

Kela drug reimbursment

Malignant tumour

+∞

307.7

1253

WF003

NOMESCO Finland

Adjuvant radiotherapy

2498.6

307.7

453

182

Kela drug reimbursment

Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide

35.6

307.7

658

233

C71.90

ICD-10 Finland

Malignant tumor in unspecified localization in the brain without histology

+∞

307.7

413

A04AA02

ATC

granisetron; systemic, transdermal

1005.9

307.7

703

G40.22

ICD-10 Finland

Complex partial epileptic seizure with secondary generalization

22.3

307.7

428

221

AAB10

NOMESCO Finland

Partial excision of intracranial lesion

523.5

307.7

1066

AA1DG

NOMESCO Finland

Very extensive MRI examination of brain with high intensity magnet

22.4

307.7

624

345

C69.30

ICD-10 Finland

Malignant tumor of the chorioidea without histology

+∞

307.7

316

C71.10

ICD-10 Finland

Malignant tumor in frontal lobe without histology

+∞

307.7

419

G40.29

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures

20.5

307.7

419

234

117

Kela drug reimbursment

Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue

143.3

307.7

226

ZX012

NOMESCO Finland

Radiotherapy with large shaped fields - isocentric therapy

439.0

307.7

418

C71.20

ICD-10 Finland

Malignant tumor in temporal lobe without histology

+∞

305.3

288

JN4BD

NOMESCO Finland

Extensive body CT

7.9

288.8

428

616

AA1BD

NOMESCO Finland

Extensive CT of head and brain

15.7

281.8

249

171

AA1CM

NOMESCO Finland

Extensive MRI examination of brain with 3 Tesla magnet

13.9

278.8

265

207

AAG00

NOMESCO Finland

Stereotactic intracranial biopsy

+∞

276.2

261

C71.1

ICD-10 Finland

Malignant neoplasm: Frontal lobe

+∞

273.0

258

CK2L4

NOMESCO Finland

Wide-field/panoramic imaging of ocular fundus

30.0

272.0

181

XCD10

NOMESCO Finland

Electrophysiological examination of eye

11.3

269.4

294

285

C71.2

ICD-10 Finland

Malignant neoplasm: Temporal lobe

+∞

268.7

254

AA1AD

NOMESCO Finland

CT of head and brain

3.6

265.4

1467

6176

C71.23

ICD-10 Finland

Malignant tumor of temporal lobe grade IV glioma

+∞

253.7

240

CKE60

NOMESCO Finland

Brachytherapy of choroid and retina

+∞

248.3

235

CKE65

NOMESCO Finland

Removal of brachytherapeutic plate from eye

+∞

245.1

232

C71.11

ICD-10 Finland

Malignant tumor of frontal lobe grade II glioma

+∞

240.8

228

C71.13

ICD-10 Finland

Malignant tumor of frontal lobe grade IV glioma

+∞

236.5

224

YA1BD

NOMESCO Finland

Extensive CT examination of head and neck for dose design of radiotherapy

418.3

236.1

234

AA1CD

NOMESCO Finland

Very extensive CT of head and brain

20.0

226.2

176

R56.8

ICD-10 Finland

Other and unspecified convulsions

6.2

226.1

420

761

N02AA05

ATC

oxycodone; systemic

4.0

225.1

803

2490

YX8VG

NOMESCO Finland

Stereotactic MRI exmaination with high intensity magnet for dose design of radiotherapy

563.3

214.8

211

C71.99

ICD-10 Finland

Malignant tumor in unspecified localization in the brain other or unspecified histology

+∞

214.1

203

WZC20

NOMESCO Finland

Multidisciplinary treatment meeting

10.2

210.4

245

259

JN4AD

NOMESCO Finland

Body CT examination

5.7

208.7

430

857

C79.30

ICD-10 Finland

Secondary malignant tumor of the cerebrum

+∞

207.7

197

WD125

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

1067.0

206.6

200

WF049

NOMESCO Finland

Radiotherapy of metastasis

537.4

205.3

202

G40.9

ICD-10 Finland

Epilepsy, unspecified

7.2

203.6

321

490

G40.12

ICD-10 Finland

Simple partial seizures with secondary generalization

20.0

203.4

158

YX8BD

NOMESCO Finland

Stereotactic extensive CT examination for dose design of radiotherapy

422.0

200.5

199

XA800

NOMESCO Finland

Neuropsychological investigation

6.4

198.4

354

614

G40.10

ICD-10 Finland

Simple partial seizures

27.6

197.9

135

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

3.6

197.2

824

2819

WF004

NOMESCO Finland

Palliative radiotherapy

2089.9

192.6

185

C69.32

ICD-10 Finland

Malignant tumor of the chorioidea melanoma

+∞

189.5

180

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

4.3

189.1

570

1550

WX882

NOMESCO Finland

High dependency care

8.1

184.6

259

346

WZC00

NOMESCO Finland

Treatment plan or consultation

3.0

182.6

1284

5942

ZX050

NOMESCO Finland

Stereotactic radiotherapy

320.7

179.0

180

C71.12

ICD-10 Finland

Malignant tumor of frontal lobe grade III glioma

+∞

177.8

169

C83.31

ICD-10 Finland

Diffuse lymphoma with large B cells

+∞

175.7

167

9440/3-C71.9

ICD-O-3

Glioblastoma, NOS, of brain, NOS

+∞

172.5

164

N03AB02

ATC

phenytoin; systemic

13.3

171.8

165

130

C71.30

ICD-10 Finland

Malignant tumor in parietal lobe without histology

+∞

170.4

162

AA1DM

NOMESCO Finland

Very extensive MRI examination of brain with 3 Tesla magnet

19.0

167.6

133

C61

ICD-10 Finland

Malignant neoplasm of prostate

349.4

166.8

167

8140/3-C61.9

ICD-O-3

Adenocarcinoma, NOS, of prostate gland

+∞

165.1

157

D43.2

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Brain, unspecified

421.4

162.0

161

ZX090

NOMESCO Finland

Other technic of radiotherapy

248.8

162.0

165

ZXE20

NOMESCO Finland

More than three and less than five hours

3.7

161.4

620

1985

ZXM00

NOMESCO Finland

Intraoperative use of ultrasonographic imaging

25.0

157.2

111

ZX070

NOMESCO Finland

Intensity modified radiotherapy

522.8

152.0

150

C44.31

ICD-10 Finland

Basocellular carcinoma of the skin on another or unspecified part of the face

28.0

152.0

103

9440/3-C71.2

ICD-O-3

Glioblastoma, NOS, of temporal lobe

+∞

151.3

144

L03AA02

ATC

filgrastim; parenteral

179.9

148.0

154

YA1VG

NOMESCO Finland

MRI examination of head and neck with high intesity magnet for dose design of radiotherapy

257.0

144.5

147

WD405

NOMESCO Finland

Simple antiboidy therapy of methastized malignancy

173.8

142.8

149

115

Kela drug reimbursment

Breast cancer

+∞

142.8

136

L03AA13

ATC

pegfilgrastim; parenteral

720.0

141.0

138

CA1AE

NOMESCO Finland

Eye and orbita ultrasound examination

21.7

138.0

103

N05BA09

ATC

clobazam; oral

19.4

136.5

107

C79.8

ICD-10 Finland

Secondary malignant neoplasm of other specified sites

+∞

136.5

130

YX9AD

NOMESCO Finland

Other CT eamination for dose design of radiotherapy

209.3

135.9

140

WX408

NOMESCO Finland

General anesthesy, balanced

2.8

135.8

928

4117

C71.21

ICD-10 Finland

Malignant tumor of temporal lobe grade II glioma

+∞

132.2

126

C71.00

ICD-10 Finland

Malignant tumor of the cerebrum except lobes and ventricles without histology

+∞

131.2

125

WZC30

NOMESCO Finland

Teaching

3.3

131.1

602

2136

D32.00

ICD-10 Finland

Benign tumor of the meninges on the outer surface of the cerebrum

10.5

130.5

146

145

R90.8

ICD-10 Finland

Other abnormal findings on diagnostic imaging of central nervous system

11.6

126.7

132

118

C71.33

ICD-10 Finland

Malignant tumor of parietal lobe grade IV glioma

+∞

122.7

117

8090/3-C44.9

ICD-O-3

Basal cell carcinoma, NOS, of skin, NOS

+∞

122.7

117

WX402

NOMESCO Finland

General anaesthesia

2.8

122.7

793

3395

N74

ICPC

Malignant neoplasm nervous system

616.5

121.0

119

ZX095

NOMESCO Finland

Combined chemoradiotherapy

+∞

120.6

115

G40.20

ICD-10 Finland

Complex partial seizures with only alteration of consciousness

12.6

120.3

119

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

4.6

119.5

307

728

C71.3

ICD-10 Finland

Malignant neoplasm: Parietal lobe

+∞

118.5

113

N05CD08

ATC

midazolam; nasal, systemic

7.0

118.2

186

281

WW500

NOMESCO Finland

Blood transfusion

7.8

117.6

167

225

9440/3-C71.1

ICD-O-3

Glioblastoma, NOS, of frontal lobe

+∞

116.4

111

WX140

NOMESCO Finland

Parabulbar anesthesy

4.6

111.6

286

676

H02AB09

ATC

hydrocortisone; systemic

7.2

110.2

168

245

9530/0-C70.0

ICD-O-3

Meningioma, NOS, of cerebral meninges

15.4

106.9

C71.22

ICD-10 Finland

Malignant tumor of temporal lobe grade III glioma

+∞

106.9

102

G40.19

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures

17.4

106.8

AA1AG

NOMESCO Finland

Short MRI examination of brain with median intensity magnet

8.7

106.3

137

164

WX404

NOMESCO Finland

Intravenous generell anesthesy

2.7

105.8

680

2879

C71.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of brain

+∞

105.8

101

PJA12

NOMESCO Finland

Sentinel node biopsy

1053.0

104.9

102

AAA10

NOMESCO Finland

Biopsy through craniotomy

359.1

104.9

105

C71.19

ICD-10 Finland

Malignant tumor of frontal lobe other or unspecified histology

+∞

103.7

H53.4

ICD-10 Finland

Visual field defects

6.7

103.1

168

263

C69.3

ICD-10 Finland

Malignant neoplasm: Choroid

+∞

102.7

G91.1

ICD-10 Finland

Obstructive hydrocephalus

21.3

102.6

L02AE02

ATC

leuprorelin; implant, parenteral

16.7

102.2

9680/3-C71.9

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of brain, NOS

+∞

101.6

C71.29

ICD-10 Finland

Malignant tumor in temporal lobe other or unspecified histology

+∞

101.6

A79

ICPC

Malignancy NOS

215.1

101.1

104

ZXE10

NOMESCO Finland

More than one and less than three hours

2.3

99.9

1199

6730

ZXE30

NOMESCO Finland

More than five and less than seven hours

4.9

98.8

228

494

ZXD10

NOMESCO Finland

Scheduled procedure

2.2

97.2

1275

7401

JN4CD

NOMESCO Finland

Very extensive body CT

9.5

97.0

116

126

D43.1

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Brain, infratentorial

133.1

96.6

103

D33.00

ICD-10 Finland

Medial pilosytic astrocytoma of the cerebrum

50.9

95.2

A02BC02

ATC

pantoprazole; systemic

2.3

94.6

2216

16122

C71.9

ICD-10 Finland

Malignant neoplasm: Brain, unspecified

+∞

94.2

L02BA01

ATC

tamoxifen; oral

43.8

93.9

N02AB03

ATC

fentanyl; nasal, sublingual, transdermal

6.2

92.2

163

277

C71.83

ICD-10 Finland

Overall malignant tumor of the brain grade IV glioma

+∞

91.1

D70.82

ICD-10 Finland

Drug-induced neutropenia

25.1

91.0

WB113

NOMESCO Finland

Multiple adjuvant cytostatic therapy

904.0

90.2

ZX080

NOMESCO Finland

Image guided radiotherapy

+∞

90.0

116

Kela drug reimbursment

Prostate cancer

+∞

87.9

C78.7

ICD-10 Finland

Secondary malignant neoplasm of liver and intrahepatic bile duct

872.2

87.1

8000/3-C71.9

ICD-O-3

Neoplasm, malignant of brain, NOS

+∞

84.8

8720/3-C69.3

ICD-O-3

Malignant melanoma, NOS, of choroid

+∞

83.7

C50.41

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor

+∞

83.7

XX2RW, ,

NOMESCO Finland

14.1

82.8

C71.80

ICD-10 Finland

Overall malignant tumor of the brain without histology

+∞

81.6

C85.9

ICD-10 Finland

Non-Hodgkin lymphoma, unspecified

+∞

81.6

C83.3

ICD-10 Finland

Diffuse large B-cell lymphoma

+∞

81.6

D32.02

ICD-10 Finland

Benign tumor of the meninges at the base of the brain

11.3

81.6

CA1CG

NOMESCO Finland

Eye and orbita extensive MRI examination with high intensity magnet

13.4

81.2

183

Kela drug reimbursment

Lamotrigin and topiramate

10.4

80.5

Z51.1

ICD-10 Finland

Chemotherapy session for neoplasm

402.5

79.2

WF029

NOMESCO Finland

Radiotherapy of local residive tumor

+∞

78.5

A04AA55

ATC

palonosetron, combinations; systemic

+∞

78.5

C70.0

ICD-10 Finland

Malignant neoplasm: Cerebral meninges

+∞

78.5

XW000

NOMESCO Finland

Bone marrow biopsy

5.6

78.0

152

283

8500/3-C50.9

ICD-O-3

Infiltrating duct carcinoma, NOS, of breast, NOS

+∞

77.4

ABB00

NOMESCO Finland

Excision of lesion of spinal canal

33.2

76.3

D31.3

ICD-10 Finland

Benign neoplasm: Choroid

6.6

75.1

123

193

G40.11

ICD-10 Finland

Simple partial epileptic seizure that develops into a complex partial seizure

24.5

74.6

WD415

NOMESCO Finland

Demanding antibody therapy of methastized malignancy

135.0

74.3

PJD52

NOMESCO Finland

Block dissection of axillary lymph nodes

+∞

74.3

R4110

NOMESCO Finland

Physiotherapy

2.1

74.2

908

5019

JN6AD

NOMESCO Finland

CT of torso and neck

12.9

73.5

R4150

NOMESCO Finland

Neuropsychological rehabilitation

11.4

72.7

N76

ICPC

Neoplasm nervous system unspecified

101.3

72.2

ZXM40

NOMESCO Finland

Use of fluorescent substance

114.3

72.2

8720/3-C69.9

ICD-O-3

Malignant melanoma, NOS, of eye, NOS

+∞

72.2

HAB40

NOMESCO Finland

Wedge excision of mammary gland

16.4

71.9

C71.40

ICD-10 Finland

Malignant tumor of the occipital lobe without histology

+∞

71.1

WC105

NOMESCO Finland

Simple cytostatic therapy of local tumor recidive

+∞

71.1

C79.5

ICD-10 Finland

Secondary malignant neoplasm of bone and bone marrow

+∞

71.1

WPA10

NOMESCO Finland

Proactive palliative care treatment plan

26.2

70.7

N03AF01

ATC

carbamazepine; oral, rectal

3.5

70.0

256

776

C71.60

ICD-10 Finland

Malignant tumor of cerebellum without histology

+∞

68.0

9380/3-C71.9

ICD-O-3

Glioma, malignant of brain, NOS

+∞

68.0

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

2.9

67.2

340

1250

9440/3-C71.3

ICD-O-3

Glioblastoma, NOS, of parietal lobe

+∞

66.9

XCK10

NOMESCO Finland

Photography of fundus of eye

2.7

66.7

410

1670

IAZ97

NOMESCO Finland

Psychiatric consultation in another specialty

7.8

65.9

121

XZZ00

NOMESCO Finland

Active surveillance of a diagnosed cancer

651.5

65.1

HAC20

NOMESCO Finland

Total mastectomy

103.8

65.1

AAF05

NOMESCO Finland

Ventriculoperitoneal shunt

6.8

64.6

102

154

9400/3-C71.1

ICD-O-3

Astrocytoma, NOS, of frontal lobe

+∞

63.8

N03AX23

ATC

brivaracetam; systemic

23.3

63.5

TAB00

NOMESCO Finland

Lumbar puncture

3.7

63.1

207

583

N03AG01

ATC

valproic acid; systemic, rectal

3.1

62.8

278

946

CK2S4

NOMESCO Finland

Plain photography of ocular fundus

3.0

62.4

290

1015

G40.21

ICD-10 Finland

Partial epileptic seizure with cloudiness and automatism

17.3

61.8

C71.31

ICD-10 Finland

Malignant tumor of the parietal lobe grand II glioma

+∞

61.7

NK6AN

NOMESCO Finland

Total body bone isotope imaging

25.6

61.5

C64.88

ICD-10 Finland

Other malignant neoplasm of kidney, except renal pelvis

+∞

60.6

C69.39

ICD-10 Finland

Malignant tumor in chorioidea other or unspecified histology

+∞

60.6

TPX10

NOMESCO Finland

Implantation of vascular injection port

5.7

59.9

113

204

D32.9

ICD-10 Finland

Benign neoplasm: Meninges, unspecified

15.0

59.7

9450/3-C71.1

ICD-O-3

Oligodendroglioma, NOS, of frontal lobe

+∞

59.6

C69.00

ICD-10 Finland

Malignant tumor of the conjunctiva without histology

+∞

59.6

L01BC06

ATC

capecitabine; oral

+∞

59.6

166

Kela drug reimbursment

Dalteparin and tinzaparin (treatment for more than 6 months)

+∞

59.6

C44.51

ICD-10 Finland

Basocellular carcinoma of the skin on the torso

25.0

59.6

L02BG04

ATC

letrozole; oral

6.8

59.0

140

R4120

NOMESCO Finland

Occupational therapy

3.0

59.0

285

1019

Z51.0

ICD-10 Finland

Radiotherapy session

302.8

58.5

R90.0

ICD-10 Finland

Intracranial space-occupying lesion

75.0

58.3

YG1BD

NOMESCO Finland

Extensive CT examination of thorax for dose design of radiotherapy

578.6

57.8

C78.0

ICD-10 Finland

Secondary malignant neoplasm of lung

+∞

57.5

QAE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in head or neck

3.8

57.4

180

491

WX872

NOMESCO Finland

Intensive care

3.2

57.3

239

784

WX002

NOMESCO Finland

Sedation and analgesia

2.1

56.1

635

3360

ZXA05

NOMESCO Finland

Left side

2.0

56.1

779

4443

WD115

NOMESCO Finland

Multiple cystostatic therapy of methastized malignancy

557.8

55.8

CFA20

NOMESCO Finland

Biopsy of conjunctiva

16.4

55.6

B01AB10

ATC

tinzaparin; parenteral

2.7

55.5

317

1239

9400/3-C71.9

ICD-O-3

Astrocytoma, NOS, of brain, NOS

+∞

55.4

Z3229

NOMESCO Finland

Other healthcare associate professional

2.6

54.5

337

1370

G40.89

ICD-10 Finland

Other epilepsy

13.6

54.5

R1230

NOMESCO Finland

Neuropsychological evaluation of need and possibilities to rehabilitation

7.6

53.9

104

CK2X4

NOMESCO Finland

Optical coherence tomography (OCT) of ocular fundus

2.5

53.7

389

1706

YX9BD

NOMESCO Finland

Other extensive CT eamination for dose design of radiotherapy

537.0

53.7

ZXA00

NOMESCO Finland

Right side

1.9

53.4

837

4965

WD135

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

+∞

53.3

C71.93

ICD-10 Finland

Malignant tumor in an unspecified localization in the brain grade IV glioma

+∞

53.3

C71.32

ICD-10 Finland

Malignant tumor of parietal lobe grade III glioma

+∞

52.2

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

2.0

51.3

672

3739

C72.00

ICD-10 Finland

Malignant tumor of the spinal cord without histology

+∞

51.2

Z2446

NOMESCO Finland

Social worker

2.9

51.2

255

926

G41.9

ICD-10 Finland

Status epilepticus, unspecified

10.7

50.6

C50.99

ICD-10 Finland

Breast, unspecified

505.9

50.6

ZX120

NOMESCO Finland

Intravenous

2.8

50.3

273

1037

C71.39

ICD-10 Finland

Malignant tumor of parietal lobe other or unspecified histology

+∞

50.1

XX9BW

NOMESCO Finland

Submitting image material and/or investigation material to authority or other institution

6.3

49.4

137

8090/3-C44.3

ICD-O-3

Basal cell carcinoma, NOS, of skin of other and unspecified parts of face

+∞

48.0

C34.1

ICD-10 Finland

Malignant neoplasm: Upper lobe, bronchus or lung

+∞

48.0

ABB10

NOMESCO Finland

Resection of lesion of spinal canal

105.8

47.9

ZSA00

NOMESCO Finland

Procedure related to previous procedure classified in chapter A

12.5

47.8

TPH04

NOMESCO Finland

Cathetrisation of vein

2.0

47.5

675

3852

N05CF01

ATC

zopiclone; oral

1.8

47.4

1023

6665

NA7CG

NOMESCO Finland

Spine and spinal cord extensive MRI examination with high intensity magnet

6.8

47.1

111

C71.89

ICD-10 Finland

Overall malignant tumor of the brain other or unspecified histology

+∞

47.0

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.7

46.8

1422

10205

C72.1

ICD-10 Finland

Malignant neoplasm: Cauda equina

+∞

45.9

C71.01

ICD-10 Finland

Malignant tumor of cerebellum except lobes and ventricles grade II glioma

+∞

45.9

B01AB05

ATC

enoxaparin; parenteral

1.8

45.5

858

5355

Z01.0

ICD-10 Finland

Examination of eyes and vision

2.0

45.5

629

3550

WW300

NOMESCO Finland

Transfer of autologic stem cells

233.3

45.1

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

2.0

44.9

575

3159

Z3231

NOMESCO Finland

Registered nurse

1.8

44.5

817

5051

WD505

NOMESCO Finland

Simple enzyme inhibitor or similar therapy of methastized malignancy

443.8

44.3

WD305

NOMESCO Finland

Simple therapy of methastized malignancy with biomodifiers

155.6

43.9

C71.43

ICD-10 Finland

Malignant tumor of the occipital lobe grade IV glioma

+∞

43.8

C83.80

ICD-10 Finland

B-cell lymphoma in marginal zone

+∞

43.8

ZX112

NOMESCO Finland

Subcutaneous

7.8

43.8

EP1AE

NOMESCO Finland

Neck ultrasound examination

3.3

43.0

168

529

Z2445

NOMESCO Finland

Psychologist

3.3

42.9

166

519

D32.0

ICD-10 Finland

Benign neoplasm: Cerebral meninges

12.5

42.7

TPH07

NOMESCO Finland

Cathetrisation of artery

2.3

42.6

351

1622

HA1AA

NOMESCO Finland

X-ray mammography

3.8

42.5

135

371

G40.2

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures

7.3

42.4

D32.01

ICD-10 Finland

Benign tumor of meninges on interhemispheric surface

11.8

42.1

A28

ICPC

Limited function/disability NOS

1.9

42.0

622

3582

XCW99

NOMESCO Finland

Other investigative procedure of eye

2.2

41.8

391

1904

C67.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of bladder

+∞

41.8

C72.9

ICD-10 Finland

Malignant neoplasm: Central nervous system, unspecified

+∞

41.8

L03AA14

ATC

lipegfilgrastim; parenteral

+∞

41.8

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

6.8

41.6

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

2.9

41.4

205

740

KCD02

NOMESCO Finland

Transurethral resection of bladder

11.2

40.7

NA7DG

NOMESCO Finland

Spine and spinal cord very extensive MRI examination with high intensity magnet

7.4

39.8

A06AH03

ATC

naloxegol; oral

11.2

39.8

CFC00

NOMESCO Finland

Excision of lesion of conjunctiva

10.6

39.3

A04AD12

ATC

aprepitant; systemic

202.5

38.9

C69.40

ICD-10 Finland

Malignant tumor of ciliary body without histology

+∞

38.6

A49.9

ICD-10 Finland

Bacterial infection, unspecified

2.2

38.4

344

1644

WX110

NOMESCO Finland

Infiltration anesthesia

1.7

38.2

2056

16762

HA1AE

NOMESCO Finland

Ultrasound examination of mammary glands

3.9

38.2

116

309

C71.4

ICD-10 Finland

Malignant neoplasm: Occipital lobe

+∞

37.6

C69.02

ICD-10 Finland

Malignant tumor in conjunctival melanoma

+∞

37.6

CAA30

NOMESCO Finland

Biopsy of orbit

101.3

36.8

Y77

ICPC

Malignant neoplasm prostate

131.6

36.8

C50.40

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, no histological veryfication

+∞

36.5

L02BB03

ATC

bicalutamide; oral

+∞

36.5

A98

ICPC

Health maint/preventive medicine

0.6

34.8

2433

26856

D31.0

ICD-10 Finland

Benign neoplasm: Conjunctiva

7.3

34.8

E23.00

ICD-10 Finland

Panhypopituitarism

10.1

34.5

C71.0

ICD-10 Finland

Malignant neoplasm: Cerebrum, except lobes and ventricles

+∞

34.4

C85.1

ICD-10 Finland

B-cell lymphoma, unspecified

+∞

34.4

WB123

NOMESCO Finland

Demanding adjuvant cytostatic therapy

+∞

34.4

YL1BD

NOMESCO Finland

Extensive CT examination of pelvis for dose design of radiotherapy

+∞

34.4

AWB00

NOMESCO Finland

Reoperation for superficial infection in surgery of the nervous system

39.6

34.3

D48.7

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Other specified sites

8.7

34.0

C71

ICD-10 Finland

Malignant neoplasm of brain

+∞

33.4

9450/3-C71.9

ICD-O-3

Oligodendroglioma, NOS, of brain, NOS

+∞

33.4

C72.09

ICD-10 Finland

Malignant tumor of the spinal cord other histology

+∞

33.4

G40

ICD-10 Finland

Epilepsy

6.0

33.4

100

WX704

NOMESCO Finland

Intubation

2.4

33.1

253

1128

WZC15, ,

NOMESCO Finland

64.1

33.0

101

Kela drug reimbursment

Anterior pituitary hypofunction

6.7

32.7

9391/3-C72.0

ICD-O-3

Ependymoma, NOS, of spinal cord

+∞

32.3

C71.69

ICD-10 Finland

Malignant tumor of the cerebellum other or unspecified histology

+∞

32.3

C71.70

ICD-10 Finland

Malignant tumor of the brainstem without histology

+∞

32.3

XX1ZW

NOMESCO Finland

Very extensive written report from radiologist

13.0

32.3

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

4.0

32.0

231

ZXD05

NOMESCO Finland

Urgent procedure

1.7

32.0

879

5993

C73.91

ICD-10 Finland

Papillary carcinoma of the thyroid gland (thyroid gland)

+∞

31.3

C50.21

ICD-10 Finland

Malignant tumor of the upper inner quadrant of the mammary gland,ductal tumor

+∞

31.3

YG1AD

NOMESCO Finland

CT examination of thorax for dose design of radiotherapy

+∞

31.3

C71.09

ICD-10 Finland

Malignant tumor of the cerebrum except lobes and ventricles other or unspecified histology

+∞

31.3

C71.6

ICD-10 Finland

Malignant neoplasm: Cerebellum

+∞

31.3

C70.9

ICD-10 Finland

Malignant neoplasm: Meninges, unspecified

+∞

31.3

PA3AC

NOMESCO Finland

Carotis angiography with X-ray

9.8

31.2

I26.9

ICD-10 Finland

Pulmonary embolism without mention of acute cor pulmonale

2.6

30.8

185

738

WX892

NOMESCO Finland

Monitored bed care

2.3

30.3

251

1158

C50.91

ICD-10 Finland

Malignant tumor in another specified localization in ductal mammary gland

+∞

30.2

8260/3-C73.9

ICD-O-3

Papillary adenocarcinoma, NOS, of thyroid gland

+∞

30.2

8120/3-C67.9

ICD-O-3

Transitional cell carcinoma, NOS, of bladder, NOS

+∞

30.2

9400/3-C71.2

ICD-O-3

Astrocytoma, NOS, of temporal lobe

+∞

30.2

C83.9

ICD-10 Finland

Non-follicular (diffuse) lymphoma, unspecified

+∞

30.2

JJ2AT

NOMESCO Finland

Biopsy of liver with ultrasound guidance

5.1

29.9

126

HA003

NOMESCO Finland

Radiotherapy after partial ablation of mammary gland

305.3

29.8

2151

FHL

Resection, big brain

156.5

29.7

ZZR00

NOMESCO Finland

Flap of skin

8.5

29.6

R47.0

ICD-10 Finland

Dysphasia and aphasia

4.9

29.2

136

C71.82

ICD-10 Finland

Overall malignant tumor of the brain grade III glioma

+∞

29.2

9510/3-C69.2

ICD-O-3

Retinoblastoma, NOS, of retina

+∞

29.2

1906B

ICD-9 Finland

Malignant neoplasm of eye, Choroid[MELANOMA CHORIOIDEAE]

+∞

29.2

C71.03

ICD-10 Finland

Malignant tumor of cerebellum except lobes and ventricles grade IV glioma

+∞

29.2

8000/3-C69.3

ICD-O-3

Neoplasm, malignant of choroid

+∞

29.2

C71.50

ICD-10 Finland

Malignant tumor of cerebral ventricle without histology

+∞

29.2

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

2.2

29.2

270

1303

GD1CT

NOMESCO Finland

Biopsy of the lung with CT guidance

9.5

28.8

CF2S4

NOMESCO Finland

Photography of conjunctiva

34.0

28.7

D41.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Kidney

5.0

28.7

123

Z2221

NOMESCO Finland

Medical doctor

1.7

28.5

738

4933

ZXE00

NOMESCO Finland

One hour or less

1.6

28.5

1044

7586

180

Kela drug reimbursment

Interferon alfa

+∞

28.2

9401/3-C71.1

ICD-O-3

Astrocytoma, anaplastic, NOS, of frontal lobe

+∞

28.2

C71.91

ICD-10 Finland

Malignant tumor in unspecified location in the brain grade II glioma

+∞

28.2

C79.31

ICD-10 Finland

Secondary malignant tumor of the cerebellum

+∞

28.2

C20.91

ICD-10 Finland

Malignant tumor of the rectum invasive carcinoma

+∞

28.2

WB203

NOMESCO Finland

Simple adjuvant hormone therapy of malignancy

+∞

28.2

R50.9

ICD-10 Finland

Fever, unspecified

1.9

28.1

433

2500

H47.2

ICD-10 Finland

Optic atrophy

9.5

28.0

AA5FG

NOMESCO Finland

Functional MRI examination of brain with high intensity magnet

284.0

27.8

WF099

NOMESCO Finland

Other radiotherapy

42.9

27.7

OAB38

NOMESCO Finland

Psychosocial guidance and counselling

42.9

27.7

XX1AD

NOMESCO Finland

Other CT-examination

101.0

27.7

WW200, ,

SPAT

0.5

27.3

400

6589

8500/3-C50.4

ICD-O-3

Infiltrating duct carcinoma, NOS, of upper-outer quadrant of breast

+∞

27.1

C50.90

ICD-10 Finland

Malignant tumor in other or unspecified location in mammary gland without histology

+∞

27.1

8090/3-C44.5

ICD-O-3

Basal cell carcinoma, NOS, of skin of trunk

+∞

27.1

WB401

NOMESCO Finland

Simple antibody therapy of primary tumour

+∞

27.1

C71.81

ICD-10 Finland

Overall malignant tumor of the brain grade II glioma

+∞

27.1

N18

ICPC

Paralysis/weakness

3.4

27.1

100

304

C34.12

ICD-10 Finland

Malignant tumor of the anterior, bronchial or pulmonary adenocarcinoma

273.3

26.8

NA7BG

NOMESCO Finland

Spine and spinal cord MRI examination with high intensity magnet

7.1

26.7

XCK00

NOMESCO Finland

Perimetry

2.3

26.7

219

1006

C64

ICD-10 Finland

Malignant neoplasm of kidney, except renal pelvis

141.2

26.6

C67.9

ICD-10 Finland

Malignant neoplasm: Bladder, unspecified

141.2

26.6

D33.08

ICD-10 Finland

Another benign tumor of the cerebral ventricle

141.2

26.6

CS424

NOMESCO Finland

Visual field testing with Goldmann perimetry

5.4

26.6

WPA15

NOMESCO Finland

Palliative care consultation with the patient and loved ones

23.4

26.1

C72.2

ICD-10 Finland

Malignant neoplasm: Olfactory nerve

+∞

26.1

WD325

NOMESCO Finland

Demanding therapy of methastized malignancy with biomodifiers

28.6

25.4

H01AC01

ATC

somatropin; parenteral

8.9

25.1

C72.01

ICD-10 Finland

Malignant tumor of the spinal cord grade II glioma

+∞

25.0

C54.11

ICD-10 Finland

Adenocarcinoma of the endometrium

+∞

25.0

8310/3-C64.9

ICD-O-3

Clear cell adenocarcinoma, NOS, of kidney, NOS

+∞

25.0

C69.03

ICD-10 Finland

Malignant tumor of conjunctival carcinoma

+∞

25.0

C50.11

ICD-10 Finland

Malignant tumor of the central part of the mammary gland,ductal tumor

+∞

25.0

C44.41

ICD-10 Finland

Basocellular carcinoma of the skin of the scalp and neck

39.1

24.9

N03AX22

ATC

perampanel; oral

26.4

24.8

YX9AW, ,

NOMESCO Finland

252.1

24.7

YX8AD

NOMESCO Finland

Stereotactic CT examination for dose design of radiotherapy

32.3

24.6

H53.2

ICD-10 Finland

Diplopia

2.8

24.5

129

481

KE3AT

NOMESCO Finland

Transrectal gold marker implantation in prostate under ultrasound guidance

+∞

24.0

8720/3-C44.5

ICD-O-3

Malignant melanoma, NOS, of skin of trunk

+∞

24.0

C83.1

ICD-10 Finland

Mantle cell lymphoma

+∞

24.0

PA7ST

NOMESCO Finland

Extensive medical infusion to cerebral artery

+∞

24.0

C79.39

ICD-10 Finland

Secondary malignant tumor of the meninges, ventricle or other part of the brain

+∞

24.0

9440/3-C71.0

ICD-O-3

Glioblastoma, NOS, of cerebrum

+∞

24.0

Z3226

NOMESCO Finland

Physiotherapist

1.7

23.9

497

3122

L02BG06

ATC

exemestane; oral

241.7

23.7

C82.1

ICD-10 Finland

Follicular lymphoma grade II

241.7

23.7

N88

ICPC

Epilepsy

6.2

23.6

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.5

23.5

828

5912

R4130

NOMESCO Finland

Speech therapy

3.0

23.3

103

349

THW99

NOMESCO Finland

Other minor procedure in surgery of mammary gland

28.4

23.1

G91.0

ICD-10 Finland

Communicating hydrocephalus

6.4

23.1

C34.90

ICD-10 Finland

Malignant tumor in unspecified location in bronchus and lung without histology

+∞

22.9

C71.59

ICD-10 Finland

Malignant tumor of cerebral ventricle other or unspecified histology

+∞

22.9

C34.3

ICD-10 Finland

Malignant neoplasm: Lower lobe, bronchus or lung

+∞

22.9

Z85.8

ICD-10 Finland

Personal history of malignant neoplasms of other organs and systems

+∞

22.9

C72.3

ICD-10 Finland

Malignant neoplasm: Optic nerve

+∞

22.9

9451/3-C71.1

ICD-O-3

Oligodendroglioma, anaplastic, NOS, of frontal lobe

+∞

22.9

C69.42

ICD-10 Finland

Malignant tumor of ciliary melanoma

+∞

22.9

G91.9

ICD-10 Finland

Hydrocephalus, unspecified

7.4

22.9

CH2S4

NOMESCO Finland

Photography of iris

65.5

22.8

YL1AD

NOMESCO Finland

CT examination of pelvis for dose design of radiotherapy

231.6

22.6

X76

ICPC

Malignant neoplasm breast female

120.9

22.6

CD2S4

NOMESCO Finland

Photography of eye

6.8

22.5

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.8

22.3

346

1996

KE1AT

NOMESCO Finland

Biopsy of prostata with ultrasoudnguidance

3.5

22.2

230

H47.1

ICD-10 Finland

Papilloedema, unspecified

7.1

22.0

C50.4

ICD-10 Finland

Malignant neoplasm: Upper-outer quadrant of breast

+∞

21.9

C71.7

ICD-10 Finland

Malignant neoplasm: Brain stem

+∞

21.9

8312/3-C64.9

ICD-O-3

Renal cell carcinoma, NOS, of kidney, NOS

+∞

21.9

C69.60

ICD-10 Finland

Malignant tumor in orbit without histology

+∞

21.9

C69.21

ICD-10 Finland

Retina

+∞

21.9

C83.39

ICD-10 Finland

Diffuse non-Hodgkin's large cell lymphoma UNS

+∞

21.9

9382/3-C71.1

ICD-O-3

Oligoastrocytoma, NOS, of frontal lobe

+∞

21.9

C69.09

ICD-10 Finland

Malignant tumor in conjunctival other or unspecified histology

+∞

21.9

WPB10

NOMESCO Finland

Making a convalescent care decision

25.2

21.7

D33.9

ICD-10 Finland

Benign neoplasm: Central nervous system, unspecified

25.2

21.7

N75

ICPC

Benign neoplasm nervous system

80.7

21.7

C90.0

ICD-10 Finland

Multiple myeloma

221.5

21.6

D33.10

ICD-10 Finland

Benign pilosytic astrocytoma of brain stem

115.8

21.6

C34.9

ICD-10 Finland

Malignant neoplasm: Bronchus or lung, unspecified

115.8

21.6

AA7AA

NOMESCO Finland

Liquor cerebri shunt X-ray examinatin without contrast

8.8

21.5

H49.2

ICD-10 Finland

Sixth [abducent] nerve palsy

5.2

21.4

9539/1-C70.0

ICD-O-3

Atypical meningioma of cerebral meninges

43.6

21.4

CBA10

NOMESCO Finland

Biopsy of eyelid

6.4

21.4

102

Kela drug reimbursment

Diabetes insipidus

26.6

21.3

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.8

21.3

322

1842

D69.5

ICD-10 Finland

Secondary thrombocytopenia

23.3

21.2

CK2A4

NOMESCO Finland

Autofluorescence imaging of ocular fundus

9.0

21.2

SPAT1153

SPAT

Removal of sutures

1.5

21.0

802

5801

C10AA07

ATC

rosuvastatin; oral

0.6

21.0

517

7549

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

2.0

21.0

235

1216

C67.2

ICD-10 Finland

Malignant neoplasm: Lateral wall of bladder

+∞

20.9

C34.10

ICD-10 Finland

Malignant tumor of the upper lobe, bronchus or lung without histology

+∞

20.9

C71.49

ICD-10 Finland

Malignant tumor in occipital lobe other or unspecified histology

+∞

20.9

L01CB01

ATC

etoposide; systemic

+∞

20.9

128

Kela drug reimbursment

Cancers of female genital organs

+∞

20.9

KEC01

NOMESCO Finland

Percutaneous endoscopic radical prostatectomy

+∞

20.9

9440/3-C71.8

ICD-O-3

Glioblastoma, NOS, of overlapping lesion of brain

+∞

20.9

WW409

NOMESCO Finland

Other aferesis

77.3

20.7

PJ5AN

NOMESCO Finland

Localisation of sentinell lymphnode with isotope imaging

110.8

20.6

AA1AA

NOMESCO Finland

Head X-ray examination

5.5

20.5

R51.80

ICD-10 Finland

Headache

1.7

20.5

438

2762

2152

FHL

Extraction, big brain

22.5

20.4

Z02.4

ICD-10 Finland

Examination for driving licence

0.6

20.3

402

6196

D32.04

ICD-10 Finland

Secondary or multiple benign tumor of the meninges above the exam

48.3

20.1

C44.30

ICD-10 Finland

Malignant tumor of the skin on another or unspecified part of the face without histology

48.3

20.1

WX302

NOMESCO Finland

Thoracal epidural anesthesy

3.1

20.1

281

JN6BD

NOMESCO Finland

Extensive CT of torso and neck

16.2

20.1

XA400

NOMESCO Finland

EEG

6.0

19.9

D31.6

ICD-10 Finland

Benign neoplasm: Orbit, unspecified

23.5

19.9

N05BA04

ATC

oxazepam; oral

1.5

19.9

731

5238

WD205

NOMESCO Finland

Therapy of methastized malignancy with hormones

+∞

19.8

C71.02

ICD-10 Finland

Malignant tumor of the cerebrum except lobes and ventricles grade III glioma

+∞

19.8

C50.42

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, lobular tumor

+∞

19.8

8140/3-C34.9

ICD-O-3

Adenocarcinoma, NOS, of lung, NOS

+∞

19.8

C50.81

ICD-10 Finland

Overall malignant tumor of the mammary gland, ductal tumor

+∞

19.8

C34.99

ICD-10 Finland

Malignant tumor in unspecified localization in bronchial and pulmonary other or unspecified histology

+∞

19.8

C71.65

ICD-10 Finland

Malignant tumor of the cerebellum primary neuroectodermal tumor

+∞

19.8

G93.6

ICD-10 Finland

Cerebral oedema

+∞

19.8

C50.49

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, other or undeterminated histology

+∞

19.8

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

2.5

19.7

125

512

JN1CG

NOMESCO Finland

Extensive MRI examination of upper part of abdomen with high intensity magnet

3.6

19.7

184

XF400

NOMESCO Finland

ECG with 12 standard connections

1.6

19.3

458

2966

AAF20

NOMESCO Finland

Revision of shunt of ventricle of brain

6.3

19.3

D43.4

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Spinal cord

46.3

19.2

R93.0

ICD-10 Finland

Abnormal findings on diagnostic imaging of skull and head, not elsewhere classified

16.8

19.1

1XC02, ,

NOMESCO Finland

7.2

19.1

Z31.5

ICD-10 Finland

Genetic counselling

2.5

19.0

121

497

WX725

NOMESCO Finland

Noninvasive ventilation

2.2

18.9

161

750

D33.05

ICD-10 Finland

Other lateral benign tumor in temporal lobe

55.3

18.9

1CD02, ,

NOMESCO Finland

+∞

18.8

PC2ET

NOMESCO Finland

Extensive embolisation of lesion of liver

+∞

18.8

9440/3-C71.4

ICD-O-3

Glioblastoma, NOS, of occipital lobe

+∞

18.8

C79.3

ICD-10 Finland

Secondary malignant neoplasm of brain and cerebral meninges

+∞

18.8

9401/3-C71.2

ICD-O-3

Astrocytoma, anaplastic, NOS, of temporal lobe

+∞

18.8

C69.20

ICD-10 Finland

Retina

+∞

18.8

C69.45

ICD-10 Finland

Melanoma of iris

+∞

18.8

3770

FHL

Placing a radiating plate on the surface of the eye with additional measures

+∞

18.8

8520/3-C50.9

ICD-O-3

Lobular carcinoma, NOS, of breast, NOS

+∞

18.8

QBE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin of trunk

2.3

18.7

138

605

WX730

NOMESCO Finland

Conventional respirator

3.6

18.7

176

T81.3

ICD-10 Finland

Disruption of operation wound, not elsewhere classified

3.3

18.6

211

22500

ICD-8 Finland

Benign neoplasm of brain and other parts of nervous system, Brain

100.6

18.6

9161/1-C71.6

ICD-O-3

Hemangioblastoma of cerebellum, NOS

100.6

18.6

OAA41

NOMESCO Finland

Health check based on individual needs

191.1

18.5

R4190

NOMESCO Finland

Nutritional therapy

2.7

18.5

101

384

A06AD11

ATC

lactulose; oral

1.6

18.5

424

2721

KAC10

NOMESCO Finland

Total nephrectomy with capsule

44.3

18.2

E23.2

ICD-10 Finland

Diabetes insipidus

21.8

18.2

Z73.3

ICD-10 Finland

Stress, not elsewhere classified

3.9

18.0

134

C10AX09

ATC

ezetimibe; oral

0.5

18.0

192

3534

N05BA06

ATC

lorazepam; systemic, sublingual

2.2

18.0

155

726

AWC00

NOMESCO Finland

Reoperation of nervous system because of deep wound infection in the nervous system

52.8

17.9

K03.82

ICD-10 Finland

Split tooth for reasons other than trauma

0.6

17.9

401

6029

ZXE40

NOMESCO Finland

More than seven and less than nine hours

3.2

17.8

217

G41.2

ICD-10 Finland

Complex partial status epilepticus

18.1

17.8

WB121

NOMESCO Finland

Demanding neoadjuvant cytostatic therapy

+∞

17.7

C85.7

ICD-10 Finland

Other specified types of non-Hodgkin lymphoma

+∞

17.7

1911X

ICD-9 Finland

Malignant neoplasm of brain, Frontal lobe[AIVOJEN OTSALOHKON SYÖPÄ,EI HISTOLOGISTA VAHVISTUST]

+∞

17.7

8140/3-C20.9

ICD-O-3

Adenocarcinoma, NOS, of rectum, NOS

+∞

17.7

WD225

NOMESCO Finland

Demanding therapy of methastized malignancy with hormones

+∞

17.7

YJ2VG

NOMESCO Finland

MRI examination of pelvis with high intensity magnet for dose design of radiotherapy

+∞

17.7

9421/1-C71.9

ICD-O-3

Pilocytic astrocytoma of brain, NOS

+∞

17.7

9401/3-C71.9

ICD-O-3

Astrocytoma, anaplastic, NOS, of brain, NOS

+∞

17.7

C69.99

ICD-10 Finland

Malignant tumor in unspecified localization in eye or other unspecified histology

+∞

17.7

YN7BD

NOMESCO Finland

Extensive CT examination of spine for dose design of radiotherapy

+∞

17.7

C34.11

ICD-10 Finland

Malignant tumor of the anterior, bronchial or pulmonary epidermoid carcinoma

+∞

17.7

XX7GT

NOMESCO Finland

Selective internal radio therapy (SIRT) with Yttrium

+∞

17.7

8380/3-C54.1

ICD-O-3

Endometrioid adenocarcinoma, NOS, of endometrium

+∞

17.7

KEC00

NOMESCO Finland

Retropubic radical prostatectomy

+∞

17.7

HAE10

NOMESCO Finland

Reconstruction of breast using graft or flap

67.0

17.7

AAF00

NOMESCO Finland

Ventriculostomy

5.2

17.7

RS221, ,

NOMESCO Finland

3.7

17.6

150

C50

ICD-10 Finland

Malignant neoplasm of breast

95.6

17.6

D38.1

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung

4.0

17.5

128

PJD41

NOMESCO Finland

Excision of cervical lymph nodes

6.6

17.5

JN1DG

NOMESCO Finland

Very extensive MRI examination of upper part of abdomen with high intensity magnet

3.7

17.5

151

G40.39

ICD-10 Finland

Other or unspecified generalized epileptic syndromes with atonic, clonic, myoclonic or tonic-clonic seizures

6.8

17.4

H02AB04

ATC

methylprednisolone; systemic

1.6

17.4

402

2582

CA1DG

NOMESCO Finland

Eye and orbita very extensive MRI examination with high intensity magnet

21.0

17.3

A07AA02

ATC

nystatin; oral

2.1

17.0

160

776

QAB10

NOMESCO Finland

Major dressing of wound of skin of head or neck

7.5

17.0

G40.09

ICD-10 Finland

Other or unspecified partial (focal) idiopathic epilepsy or epileptic syndrome with local onset

7.2

16.9

L28

ICPC

Limited function/disability (L)

1.5

16.9

561

3917

TPH30

NOMESCO Finland

Insertion of central venous catheter through periferal vein

3.5

16.9

169

ZXH01

NOMESCO Finland

Procedure performed within operation theatre

22.0

16.8

PA2BD

NOMESCO Finland

Extensive CT angiography of brain

3.4

16.8

179

23810

ICD-8 Finland

Neoplasm of unspecified nature of eye, brain and other parts of nervous system, Brain

63.7

16.7

2159

FHL

Other measure in this category

63.7

16.7

CDC10

NOMESCO Finland

Enucleation of eye with insertion of prosthesis

63.7

16.7

CDC00

NOMESCO Finland

Enucleation of eye

63.7

16.7

8090/3-C44.6

ICD-O-3

Basal cell carcinoma, NOS, of skin of upper limb and shoulder

+∞

16.7

19109

ICD-8 Finland

Malignant neoplasm of brain, Unspecified

+∞

16.7

9699/3-C69.0

ICD-O-3

Marginal zone B-cell lymphoma, NOS, of conjunctiva

+∞

16.7

C43.52

ICD-10 Finland

Malignant melanoma on the torso: 'superficial spreading' type

+∞

16.7

C71.74

ICD-10 Finland

Malignant tumor of the brainstem ependyoma

+∞

16.7

YNB10

NOMESCO Finland

Collection of stem cells for transplant

+∞

16.7

8070/3-C44.9

ICD-O-3

Squamous cell carcinoma, NOS, of skin, NOS

+∞

16.7

L02BG03

ATC

anastrozole; oral

35.2

16.7

GD1AA, ,

SPAT

0.5

16.7

144

2846

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

2.0

16.6

197

1039

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

0.6

16.6

332

5138

D33.14

ICD-10 Finland

Hemangioblastoma and cerebellum

90.5

16.6

FM1FN

NOMESCO Finland

Heart function isotope examination

170.8

16.5

XX9XW, ,

NOMESCO Finland

6.0

16.5

HA6AA

NOMESCO Finland

Extra corporeal mammography of operated mammary gland

6.3

16.3

D69.6

ICD-10 Finland

Thrombocytopenia, unspecified

3.4

16.3

178

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

2.1

16.2

149

716

ZXE17

NOMESCO Finland

Procedure duration 150 to 179 minutes

4.3

16.2

PA4AC

NOMESCO Finland

Vertebralis angiography with X-ray

12.8

16.1

ZXY02

NOMESCO Finland

Neuropsychologist

6.0

16.0

ZX108

NOMESCO Finland

Inhalation

6.0

16.0

D33.4

ICD-10 Finland

Benign neoplasm: Spinal cord

47.7

16.0

HA1AT

NOMESCO Finland

Biopsy of mammary glands with ultrasound guidance

5.6

16.0

QAE99

NOMESCO Finland

Other excision or repair surgery of skin and subcutaneous tissue in head and neck

3.9

16.0

123

L03

ICPC

Low back symptom/complaint

0.6

16.0

415

6055

Z08.0

ICD-10 Finland

Follow-up examination after surgery for malignant neoplasm

21.0

16.0

OAB43, ,

SPAT

0.6

15.9

352

5325

N28

ICPC

Limited function/disability (N)

2.9

15.8

249

PJA10

NOMESCO Finland

Exploration of lymph nodes

6.6

15.7

ZXE15

NOMESCO Finland

Procedure duration 120 to 149 minutes

3.2

15.7

192

D33.02

ICD-10 Finland

Another benign medial tumor of the cerebrum

33.5

15.7

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

1.7

15.7

292

1771

C50.51

ICD-10 Finland

Malignant tumor of the lower outer quadrant of the mammary gland, ductal tumor

+∞

15.6

PJD64

NOMESCO Finland

Laparoscopic dissection of iliac lymph nodes

+∞

15.6

C71.51

ICD-10 Finland

Malignant tumor of cerebral ventricle ependymoma

+∞

15.6

9699/3-C69.6

ICD-O-3

Marginal zone B-cell lymphoma, NOS, of orbit, NOS

+∞

15.6

CBB50

NOMESCO Finland

Excision of lesion of eyelid and reconstruction using graft or flap

+∞

15.6

8090/3-C44.1

ICD-O-3

Basal cell carcinoma, NOS, of eyelid

+∞

15.6

NA2CG

NOMESCO Finland

Thoracal spine extensive MRI examination with high intensity magnet

4.6

15.6

C44.11

ICD-10 Finland

Basocellular carcinoma of the skin of the eyelids including the corner of the eye

85.5

15.6

D43.7

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Other parts of central nervous system

85.5

15.6

TAA40

NOMESCO Finland

Cathetrisation of cerebrospinal fluid through skin

11.8

15.5

CAB00

NOMESCO Finland

Anterior orbitotomy with excision of lesion

160.8

15.5

C18.71

ICD-10 Finland

Malignant tumor of the sigmoid invasive carcinoma

160.8

15.5

D33.12

ICD-10 Finland

Cerebellum

160.8

15.5

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.6

15.5

449

3040

ZXC96

NOMESCO Finland

Robot assisted procedure

6.2

15.5

H40.5

ICD-10 Finland

Glaucoma secondary to other eye disorders

3.9

15.5

117

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

1.8

15.3

242

1399

PJ3AT

NOMESCO Finland

Cytology of lymphnode with ultrasound guidance

12.4

15.3

CA1BG

NOMESCO Finland

Eye and orbita MRI examination with high intensity magnet

7.0

15.3

G40.1

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures

7.0

15.3

CS494

NOMESCO Finland

Other visual field testing

2.6

15.2

345

S18

ICPC

Laceration/cut

1.4

15.1

1228

10060

D42.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Cerebral meninges

45.2

15.1

HAE20

NOMESCO Finland

Reconstruction of areola and mamilla using graft or flap

45.2

15.1

ZXM20

NOMESCO Finland

Intraoperative use of computerised tomography

4.2

15.0

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

2.1

15.0

149

739

AA1BM

NOMESCO Finland

MRI examination of brain with 3 Tesla magnet

3.7

14.9

125

D32.1

ICD-10 Finland

Benign neoplasm: Spinal meninges

15.1

14.9

Z08.7

ICD-10 Finland

Follow-up examination after combined treatment for malignant neoplasm

56.9

14.8

D70.89

ICD-10 Finland

Neutropenic splenomegaly

5.0

14.8

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

1.9

14.7

188

1017

D33.2

ICD-10 Finland

Benign neoplasm: Brain, unspecified

21.1

14.6

C18.70

ICD-10 Finland

Malignant tumor of the sigmoid without histology

+∞

14.6

C71.61

ICD-10 Finland

Malignant tumor of cerebellum grade II glioma

+∞

14.6

C25.0

ICD-10 Finland

Malignant neoplasm: Head of pancreas

+∞

14.6

ZX013

NOMESCO Finland

Radiotherapy with large shaped fields - SSD therapy

+∞

14.6

C34.19

ICD-10 Finland

Malignant tumor of the upper lobe, bronchus or lung other or unspecified histology

+∞

14.6

8500/2-C50.9

ICD-O-3

Intraductal carcinoma, noninfiltrating, NOS, of breast, NOS

+∞

14.6

PJD71

NOMESCO Finland

Extended sparing excision of cervical lymph nodes

+∞

14.6

C73.90

ICD-10 Finland

Malignant tumor of the thyroid gland (thyroid gland) without histology

+∞

14.6

C69.63

ICD-10 Finland

Malignant tumor of orbital carcinoma

+∞

14.6

C34.32

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung adenocarcinoma

+∞

14.6

C83.00

ICD-10 Finland

Lymphocytic lymphoma

+∞

14.6

8041/3-C34.9

ICD-O-3

Small cell carcinoma, NOS, of lung, NOS

+∞

14.6

D33.0

ICD-10 Finland

Benign neoplasm: Brain, supratentorial

+∞

14.6

8140/3-C34.1

ICD-O-3

Adenocarcinoma, NOS, of upper lobe, lung

+∞

14.6

9450/3-C71.2

ICD-O-3

Oligodendroglioma, NOS, of temporal lobe

+∞

14.6

L03AB05

ATC

interferon alfa-2b; parenteral

+∞

14.6

C72.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of brain and other parts of central nervous system

+∞

14.6

8000/3-C34.9

ICD-O-3

Neoplasm, malignant of lung, NOS

+∞

14.6

3779

FHL

Other operations in this group include disc removal

80.5

14.6

GDC01

NOMESCO Finland

Thoracoscopic lobectomy of lung

80.5

14.6

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

2.3

14.5

112

502

D33.41

ICD-10 Finland

Myxopapillary epndymoma of the spinal cord (grade I)

150.7

14.5

C50.9

ICD-10 Finland

Malignant neoplasm: Breast, unspecified

150.7

14.5

C43.59

ICD-10 Finland

Malignant melanoma of the trunk other or unspecified histology

150.7

14.5

AAF25

NOMESCO Finland

Removal of shunt of ventricle of brain

12.6

14.4

I25.1

ICD-10 Finland

Atherosclerotic heart disease

0.6

14.2

372

5433

AA5BD

NOMESCO Finland

CT of cerebral ischaemia

2.6

14.0

324

TPX15

NOMESCO Finland

Removal of vascular injection port

15.8

13.9

ZXE06

NOMESCO Finland

Procedure duration 50 to 59 minutes

2.1

13.9

129

623

R03AC02

ATC

salbutamol; inhalant

0.7

13.9

1053

12738

L13

ICPC

Hip symptom/complaint

0.6

13.6

238

3827

D48.5

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Skin

2.1

13.6

131

642

YNB00

NOMESCO Finland

Excision of bone marrow for transplantation

75.5

13.6

CAD00

NOMESCO Finland

Exenteration of orbit with use of graft or flap

+∞

13.5

WF001

NOMESCO Finland

Preoperative radiotherapy

+∞

13.5

9450/3-C71.3

ICD-O-3

Oligodendroglioma, NOS, of parietal lobe

+∞

13.5

AA5JS

NOMESCO Finland

Extensive PET-MRI of brain metabolism

+∞

13.5

C71.42

ICD-10 Finland

Malignant tumor of the occipital lobe grade III glioma

+∞

13.5

C69.0

ICD-10 Finland

Malignant neoplasm: Conjunctiva

+∞

13.5

C15.5

ICD-10 Finland

Malignant neoplasm: Lower third of oesophagus

+∞

13.5

WB133

NOMESCO Finland

Very demanding adjuvant cytostatic therapy

+∞

13.5

D47.3

ICD-10 Finland

Essential (haemorrhagic) thrombocythaemia

+∞

13.5

163

Kela drug reimbursment

Abiraterone and enzalutamide

+∞

13.5

C34.82

ICD-10 Finland

Malignant overall tumor of bronchial and pulmonary adenocarcinoma

+∞

13.5

C71.92

ICD-10 Finland

Malignant tumor in an unspecified localization in the brain grade III glioma

+∞

13.5

8720/3-C44.9

ICD-O-3

Malignant melanoma, NOS, of skin, NOS

+∞

13.5

197

Kela drug reimbursment

Sunitinib

+∞

13.5

8010/3-C34.9

ICD-O-3

Carcinoma, NOS, of lung, NOS

+∞

13.5

9522/3-C30.0

ICD-O-3

Olfactory neuroblastoma of nasal cavity

+∞

13.5

C82.2

ICD-10 Finland

Follicular lymphoma grade III, unspecified

+∞

13.5

SPAT1226

SPAT

Implementation of occupational therapy rehabilitation plan

2.5

13.5

330

UGC12

NOMESCO Finland

Flexible bronchoscopy

1.9

13.5

175

952

ZXE05

NOMESCO Finland

Procedure duration 40 to 49 minutes

2.1

13.5

129

631

C20

ICD-10 Finland

Malignant neoplasm of rectum

140.6

13.5

D33.03

ICD-10 Finland

Pilosytic lateral astrocytoma of the strobe brain

140.6

13.5

2396A

ICD-9 Finland

Neoplasm of unspecified nature, Brain

140.6

13.5

CAW99

NOMESCO Finland

Other operation on orbit

140.6

13.5

N02BE01

ATC

paracetamol; systemic, rectal

1.4

13.4

2522

23317

SPAT1229

SPAT

Assessment of need for aid

1.8

13.4

215

1249

Z97.0

ICD-10 Finland

Presence of artificial eye

25.8

13.4

C44.32

ICD-10 Finland

Spinocellular carcinoma of the skin on another or unspecified part of the face

25.8

13.4

AAK00

NOMESCO Finland

Cranioplasty

18.3

13.4

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

0.7

13.3

408

5779

PH1AE

NOMESCO Finland

Ultrasound examination of upper extremity veins

3.4

13.3

140

OAB42, ,

SPAT

0.5

13.2

137

2558

I61.9

ICD-10 Finland

Intracerebral haemorrhage, unspecified

2.8

13.2

230

N03AF04

ATC

eslicarbazepine; oral

40.2

13.1

D05.1

ICD-10 Finland

Intraductal carcinoma in situ

40.2

13.1

F80.1

ICD-10 Finland

Expressive language disorder

3.8

13.1

103

ZXD35

NOMESCO Finland

Usual procedure

2.3

13.1

415

AA5DR

NOMESCO Finland

Brain metabolism PET with CT

15.1

13.1

N02AA01

ATC

morphine; systemic, rectal

3.4

13.0

137

308

Kela drug reimbursment

Alprostadil, sildenafil and combination product containing aviptadil and phentolamine

16.8

13.0

D31.4

ICD-10 Finland

Benign neoplasm: Ciliary body

28.5

12.9

OAA67, ,

SPAT

0.5

12.9

157

2791

N19

ICPC

Speech disorder

3.0

12.9

184

JN4JR

NOMESCO Finland

Whole body extensive metabolic PET with CT

14.1

12.7

QX3AT

NOMESCO Finland

Ultrasound guided biopsy of subcutaneous tissue

9.7

12.7

SPAT1245

SPAT

Provision of support and information to patient’s family members

2.1

12.7

122

598

N03AX11

ATC

topiramate; oral

2.6

12.7

275

ZX100

NOMESCO Finland

Oral

3.5

12.6

120

TKC20

NOMESCO Finland

Catheterisation of bladder

1.8

12.6

184

1040

L01CA04

ATC

vinorelbine; systemic

+∞

12.5

C34.92

ICD-10 Finland

Malignant tumor in unspecified localization in bronchial and pulmonary adenocarcinoma

+∞

12.5

19100

ICD-8 Finland

Malignant neoplasm of brain, Lobi frontalis

+∞

12.5

9382/3-C71.9

ICD-O-3

Oligoastrocytoma, NOS, of brain, NOS

+∞

12.5

L02AE04

ATC

triptorelin; parenteral

+∞

12.5

9470/3-C71.6

ICD-O-3

Medulloblastoma, NOS, of cerebellum, NOS

+∞

12.5

19107

ICD-8 Finland

Malignant neoplasm of brain, Cerebelli

+∞

12.5

C82.01

ICD-10 Finland

Follicular nodular lymphoma, grade I

+∞

12.5

C50.82

ICD-10 Finland

Overall malignant tumor of the mammary gland, lobular tumor

+∞

12.5

L02BX03

ATC

abiraterone; oral

+∞

12.5

ZX131

NOMESCO Finland

Intrathecal

+∞

12.5

C82.9

ICD-10 Finland

Follicular lymphoma, unspecified

+∞

12.5

C80

ICD-10 Finland

Malignant neoplasm, without specification of site

+∞

12.5

HA013

NOMESCO Finland

Radiotherapy after total ablation of mammary gland

+∞

12.5

C43.50

ICD-10 Finland

Malignant melanoma of the torso without histology

+∞

12.5

C44.61

ICD-10 Finland

Basocellular carcinoma of the skin of the upper extremity including the shoulder

+∞

12.5

1922A

ICD-9 Finland

Malignant neoplasm of other and unspecified parts of nervous system, Spinal cord

+∞

12.5

C71.79

ICD-10 Finland

Malignant tumor of the brainstem other or unspecified histology

+∞

12.5

C80.99

ICD-10 Finland

Malignant tumor without specified localization or histology

+∞

12.5

C91.1

ICD-10 Finland

Chronic lymphocytic leukaemia of B-cell type

24.4

12.5

C43.99

ICD-10 Finland

Unspecified localization of malignant melanoma of the skin other or unspecified histology

130.5

12.4

PA2AD

NOMESCO Finland

CT angiography of brain

3.8

12.4

G06.0

ICD-10 Finland

Intracranial abscess and granuloma

13.2

12.4

ZX121

NOMESCO Finland

Central venous catheter

13.2

12.4

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

2.2

12.3

102

472

AAA00

NOMESCO Finland

Exploratory craniotomy

37.7

12.2

J01MA12

ATC

levofloxacin; systemic

1.5

12.1

443

3141

N03AX09

ATC

lamotrigine; oral

2.0

12.1

127

643

H01BA02

ATC

desmopressin; nasal, systemic, sublingual

2.8

12.1

213

H26.2

ICD-10 Finland

Complicated cataract

3.2

12.0

144

D32.07

ICD-10 Finland

Secondary or multiple benign tumor of the meninges below the exam

18.1

12.0

R41.0

ICD-10 Finland

Disorientation, unspecified

2.1

12.0

109

523

JN6DR

NOMESCO Finland

PET-CT of whole body metabolism

5.7

11.9

Z76.0

ICD-10 Finland

Issue of repeat prescription

0.7

11.9

394

5516

Z90.0

ICD-10 Finland

Acquired absence of part of head and neck

13.4

11.9

G81.9

ICD-10 Finland

Hemiplegia, unspecified

3.4

11.9

125

E78.0

ICD-10 Finland

Pure hypercholesterolaemia

0.7

11.9

327

4750

Q85.01

ICD-10 Finland

Neurofibromatosis, type 2

46.8

11.9

SPAT1290

SPAT

Preparation of deceased person

46.8

11.9

D33.43

ICD-10 Finland

Spinal cord

46.8

11.9

C43.5

ICD-10 Finland

Malignant neoplasm: Malignant melanoma of trunk

46.8

11.9

Q85.00

ICD-10 Finland

Neurofibromatosis, type 1

11.7

11.8

Z94.8

ICD-10 Finland

Other transplanted organ and tissue status

14.7

11.8

XX1XW

NOMESCO Finland

Extensive written report from radiologist

2.8

11.6

206

D33.30

ICD-10 Finland

Acoustic neuroma

4.6

11.6

D33.7

ICD-10 Finland

Benign neoplasm: Other specified parts of central nervous system

30.1

11.6

D33.40

ICD-10 Finland

Benign glioma of the spinal cord (grade I)

30.1

11.6

M25.5

ICD-10 Finland

Pain in joint

0.7

11.6

517

6859

CS444

NOMESCO Finland

Visual field testing with Octopus automated perimetry

2.2

11.6

100

470

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

0.7

11.6

862

10553

C44.21

ICD-10 Finland

Basocellular carcinoma of the skin of the outer ear and the outer ear canal

65.2

11.6

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

1.9

11.6

134

702

QBA25

NOMESCO Finland

Destruction of lesion of skin of trunk

4.1

11.6

TQW99

NOMESCO Finland

Other minor procedure on skin

2.2

11.5

445

G82.2

ICD-10 Finland

Paraplegia, unspecified

5.3

11.5

N03AX15

ATC

zonisamide; oral

11.1

11.5

C10AA05

ATC

atorvastatin; oral

0.7

11.5

809

9988

8097/3-C44.9

ICD-O-3

Basal cell carcinoma, nodular of skin, NOS

+∞

11.5

WD515

NOMESCO Finland

Demanding therapy of malignancy with enzyme inhibitors and similar treatments

+∞

11.5

D43

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour of brain and central nervous system

+∞

11.5

C72.0

ICD-10 Finland

Malignant neoplasm: Spinal cord

+∞

11.5

3AA13, ,

NOMESCO Finland

+∞

11.5

C69.90

ICD-10 Finland

Malignant tumor in unspecified localization in eye without histology

+∞

11.5

C79.41

ICD-10 Finland

Secondary malignant tumor of optic nerve and eye

+∞

11.5

C70.1

ICD-10 Finland

Malignant neoplasm: Spinal meninges

+∞

11.5

C67.0

ICD-10 Finland

Malignant neoplasm: Trigone of bladder

+∞

11.5

9591/3-C71.9

ICD-O-3

Malignant lymphoma, non-Hodgkin, NOS, of brain, NOS

+∞

11.5

AA003

NOMESCO Finland

Adjuvant radiotherapy of brain

+∞

11.5

C73.92

ICD-10 Finland

Follicular carcinoma of the thyroid gland

+∞

11.5

C34.00

ICD-10 Finland

Malignant tumor of the main bronchus without histology

+∞

11.5

8500/3-C50.2

ICD-O-3

Infiltrating duct carcinoma, NOS, of upper-inner quadrant of breast

+∞

11.5

9380/3-C71.1

ICD-O-3

Glioma, malignant of frontal lobe

+∞

11.5

C34.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of bronchus and lung

+∞

11.5

Z85.7

ICD-10 Finland

Personal history of other malignant neoplasms of lymphoid, haematopoietic and related tissues

+∞

11.5

JJ1AQ

NOMESCO Finland

Liver SPECT with low dose CT

+∞

11.5

C69.2

ICD-10 Finland

Malignant neoplasm: Retina

+∞

11.5

C69.69

ICD-10 Finland

Malignant tumor in orbital other or unspecified histology

+∞

11.5

C69.29

ICD-10 Finland

Retina

+∞

11.5

C50.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of breast

+∞

11.5

ZXE13

NOMESCO Finland

Procedure duration 90 to 119 minutes

2.2

11.4

414

9421/1-C71.6

ICD-O-3

Pilocytic astrocytoma of cerebellum, NOS

120.4

11.4

C30.0

ICD-10 Finland

Malignant neoplasm: Nasal cavity

120.4

11.4

C34.39

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung other or unspecified histology

120.4

11.4

C77.0

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Lymph nodes of head, face and neck

120.4

11.4

D41.4

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Bladder

4.7

11.4

NA1CG

NOMESCO Finland

Cervical spine extensive MRI examination with high intensity magnet

2.8

11.3

209

CKD05

NOMESCO Finland

Puncture of vitreous body with injection of medication

1.9

11.3

146

794

M75.1

ICD-10 Finland

Rotator cuff syndrome

0.7

11.3

384

5349

AAF15

NOMESCO Finland

Ventriculoatrial shunt

10.6

11.2

ZXA10

NOMESCO Finland

Bilateral

1.4

11.2

465

3373

NK6QA

NOMESCO Finland

Measurement of bone density from two or more locations with X-ray

2.0

11.2

128

668

N29

ICPC

Neurological sympt/complt other

2.5

11.2

263

EN1BD

NOMESCO Finland

Very extensive CT examination of mouth and soft tissues of neck

3.9

11.1

RS222, ,

NOMESCO Finland

3.4

11.1

116

M79.6

ICD-10 Finland

Pain in limb

0.7

11.0

790

9737

EP1CG

NOMESCO Finland

Extensive MRI examination of soft tissue of neck with high intesity magnet

4.0

10.9

WX142

NOMESCO Finland

Sub-tenon anesthesy

3.8

10.9

D33.15

ICD-10 Finland

Another benign tumor of the cerebellum

43.5

10.9

ZXE21

NOMESCO Finland

Procedure duration at least 3 but less than 4 hours

5.4

10.9

PA7RT

NOMESCO Finland

Medical infusion to cerebral artery

17.9

10.7

H49.0

ICD-10 Finland

Third [oculomotor] nerve palsy

4.7

10.7

R83

ICPC

Respiratory infection other

0.7

10.6

334

4734

NG1AA, ,

SPAT

0.4

10.6

1296

C20.90

ICD-10 Finland

Malignant tumor of the rectum without histology

60.2

10.6

HA4AT

NOMESCO Finland

Labeling mammary gland pathology with ultrasound guidance

5.3

10.6

CA1CM

NOMESCO Finland

Eye and orbita extensive MRI examination with 3 Tesla magnet

10.1

10.5

OAB48, ,

SPAT

0.6

10.5

155

2612

C44.62

ICD-10 Finland

Spinocellular carcinoma of the skin of the upper extremity including the shoulder

110.4

10.4

C81.9

ICD-10 Finland

Hodgkin lymphoma, unspecified

110.4

10.4

9707

FHL

Ablation of mammae and removal of axillary lymph nodes

+∞

10.4

9732/3-C42.1

ICD-O-3

Plasma cell myeloma of bone marrow

+∞

10.4

C77.8

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Lymph nodes of multiple regions

+∞

10.4

C73

ICD-10 Finland

Malignant neoplasm of thyroid gland

+∞

10.4

8000/3-C80.9

ICD-O-3

Neoplasm, malignant of unknown primary site

+∞

10.4

WC115

NOMESCO Finland

Cytostatic therapy of local tumor recidive with multiple drugs

+∞

10.4

C71.63

ICD-10 Finland

Malignant tumor of cerebellum grade IV glioma

+∞

10.4

C44.39

ICD-10 Finland

Malignant tumor of the skin on another or unspecified part of the face other or unspecified histology

+∞

10.4

YG1CD

NOMESCO Finland

Very extensive CT examination of thorax for dose design of radiotherapy

+∞

10.4

C77.1

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Intrathoracic lymph nodes

+∞

10.4

1916A

ICD-9 Finland

Malignant neoplasm of brain, Cerebellum[PIKKUAIVOJEN SYÖPÄ, ASTROCYTOMA (GR I-II)]

+∞

10.4

159

Kela drug reimbursment

Pazopanib

+∞

10.4

9530/3-C70.0

ICD-O-3

Meningioma, malignant of cerebral meninges

+∞

10.4

AA5FK

NOMESCO Finland

Functional assessment (fMRI) of brain

+∞

10.4

C50.2

ICD-10 Finland

Malignant neoplasm: Upper-inner quadrant of breast

+∞

10.4

19003

ICD-8 Finland

Malignant neoplasm of eye, Retinae

+∞

10.4

Z85.3

ICD-10 Finland

Personal history of malignant neoplasm of breast

+∞

10.4

TQW20

NOMESCO Finland

Tatoe

32.6

10.3

Q85.0

ICD-10 Finland

Neurofibromatosis (nonmalignant)

32.6

10.3

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

2.0

10.3

114

589

SAA01

NOMESCO Finland

Simple examination of mouth

0.8

10.3

1537

17275

ZZQ00

NOMESCO Finland

Free microvascular graft of skin

18.8

10.3

R11

ICD-10 Finland

Nausea and vomiting

1.6

10.2

213

1332

N06DX01

ATC

memantine; oral

0.5

10.2

1625

AWE00

NOMESCO Finland

Reoperation for deep heamorrhage in surgery of the nervous system

13.1

10.1

EB1VA, ,

NOMESCO Finland

0.6

10.1

224

3417

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

1.7

10.1

204

1264

M54.5

ICD-10 Finland

Low back pain

0.7

9.9

619

7818

PA7AD

NOMESCO Finland

CT angiography of head and neck vasculature

1.9

9.9

113

590

PJ2AT

NOMESCO Finland

Biopsy of lymphnode with ultrasound guidance

16.7

9.9

R1260

NOMESCO Finland

Evaluation of communicative skills

2.6

9.9

225

U07.2

ICD-10 Finland

COVID-19, virus not identified

0.6

9.9

209

3222

HAB50

NOMESCO Finland

Partial excision of mammary gland with reconstructive operation

26.1

9.8

T85.0

ICD-10 Finland

Mechanical complication of ventricular intracranial (communicating) shunt

10.6

9.8

AAF99

NOMESCO Finland

Other shunt operation on ventricle of brain or intracerebral cyst

9.5

9.7

L15

ICPC

Knee symptom/complaint

0.7

9.7

386

5247

2252A

ICD-9 Finland

Benign neoplasm of brain and other parts of nervous system, Cerebral meninges

13.4

9.7

D31.2

ICD-10 Finland

Benign neoplasm: Retina

13.4

9.7

F74

ICPC

Neoplasm of eye/adnexa

55.2

9.6

M01AH05

ATC

etoricoxib; oral

0.8

9.6

1260

14447

QAA50

NOMESCO Finland

Cryotherapy of skin of head or neck

5.0

9.6

JN3CD

NOMESCO Finland

Abdominal CT examination both without and with contrast

2.4

9.6

271

G41.0

ICD-10 Finland

Grand mal status epilepticus

11.4

9.5

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

1.9

9.5

122

663

D32.05

ICD-10 Finland

Cerebral meninges

10.0

9.5

D32.06

ICD-10 Finland

Benign tumor of the meninges os petrosum or clivus area

15.1

9.5

CCA10

NOMESCO Finland

Biopsy of lacrimal gland

100.3

9.4

AA5NK

NOMESCO Finland

Tractography within white matter of central nervous system

100.3

9.4

Z51.3

ICD-10 Finland

Blood transfusion (without reported diagnosis)

100.3

9.4

R05

ICPC

Cough

0.7

9.4

371

5050

S77

ICPC

Malignant neoplasm of skin

17.6

9.4

C18.20

ICD-10 Finland

Malignant tumor of the ascending colon without histology

+∞

9.4

C44.10

ICD-10 Finland

Malignant tumor of the skin of the eyelids including the corner of the eye without histology

+∞

9.4

8070/3-C34.9

ICD-O-3

Squamous cell carcinoma, NOS, of lung, NOS

+∞

9.4

C69.9

ICD-10 Finland

Malignant neoplasm: Eye, unspecified

+∞

9.4

8000/3-C71.1

ICD-O-3

Neoplasm, malignant of frontal lobe

+∞

9.4

PC2DT

NOMESCO Finland

Embolisation of lesion of liver

+∞

9.4

8720/3-C69.0

ICD-O-3

Malignant melanoma, NOS, of conjunctiva

+∞

9.4

1905A

ICD-9 Finland

Malignant neoplasm of eye, Retina[RETINOBLASTOMA RETINAE]

+∞

9.4

8090/3-C44.4

ICD-O-3

Basal cell carcinoma, NOS, of skin of scalp and neck

+∞

9.4

8070/3-C44.3

ICD-O-3

Squamous cell carcinoma, NOS, of skin of other and unspecified parts of face

+∞

9.4

C50.31

ICD-10 Finland

Malignant tumor of the lower inner quadrant of the mammary gland, ductal tumor

+∞

9.4

JN5PN

NOMESCO Finland

Isotope imaging of secondary neoplasms of thyroid origin

+∞

9.4

9400/3-C71.0

ICD-O-3

Astrocytoma, NOS, of cerebrum

+∞

9.4

8330/3-C73.9

ICD-O-3

Follicular carcinoma, NOS, of thyroid gland

+∞

9.4

9391/3-C71.7

ICD-O-3

Ependymoma, NOS, of brain stem

+∞

9.4

WW402

NOMESCO Finland

Leucoferesis

+∞

9.4

352

Kela drug reimbursment

Abiraterone and enzalutamide

+∞

9.4

19101

ICD-8 Finland

Malignant neoplasm of brain, Lobi temporalis

+∞

9.4

C56.71

ICD-10 Finland

Serous epithelial malignant tumor of the ovary

+∞

9.4

C43.72

ICD-10 Finland

Malignant melanoma of the lower extremity including the hip: 'superficial spreading' type

+∞

9.4

C71.71

ICD-10 Finland

Malignant tumor of the brainstem grade II glioma

+∞

9.4

YN7AD

NOMESCO Finland

CT examination of spine for dose design of radiotherapy

+∞

9.4

C50.10

ICD-10 Finland

Malignant tumor of the central part of the mammary gland, no histological veryfication

+∞

9.4

9380/3-C71.2

ICD-O-3

Glioma, malignant of temporal lobe

+∞

9.4

XX2XW

NOMESCO Finland

Other teleradiological consultation

8.0

9.3

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

1.6

9.3

217

1393

A86

ICD-10 Finland

Unspecified viral encephalitis

4.5

9.3

J17.3*B59

ICD-10 Finland

Pneumonia due to Pneumocystis carinii

8.7

9.3

WZC00, ,

SPAT

0.6

9.3

182

2857

WX006

NOMESCO Finland

Intravenous sedation or analgesia without general anesthesia

1.7

9.2

174

1059

D37.7

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Other digestive organs

3.0

9.2

136

H49.1

ICD-10 Finland

Fourth [trochlear] nerve palsy

4.2

9.2

G30.1

ICD-10 Finland

Alzheimer disease with late onset

0.4

9.2

1300

C01DA14

ATC

isosorbide mononitrate; oral

0.7

9.1

249

3636

B01AB04

ATC

dalteparin; parenteral

1.9

9.1

109

580

Q85.09

ICD-10 Finland

Unspecified neurofibromatosis

11.5

9.1

WPA13

NOMESCO Finland

Palliative consultation

8.3

9.1

H05.9

ICD-10 Finland

Disorder of orbit, unspecified

36.8

9.0

E23.01

ICD-10 Finland

Isolated deficiency of growth hormone

9.0

206

Kela drug reimbursment

Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease

0.7

9.0

304

4260

N05AD01

ATC

haloperidol; systemic

2.1

8.9

430

AAF50

NOMESCO Finland

Third ventriculostomy

18.6

8.9

2250A

ICD-9 Finland

Benign neoplasm of brain and other parts of nervous system, Brain

24.1

8.9

2132

FHL

Ventricular operators sunt

24.1

8.9

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

2.1

8.9

371

PJD42

NOMESCO Finland

Excision of axillary lymph nodes

12.6

8.9

A10BK03

ATC

empagliflozin; oral

0.6

8.8

110

1941

504

Kela drug reimbursment

Conditions requiring daily forced enteral nutrition

3.4

8.7

R03DC03

ATC

montelukast; oral

0.6

8.7

199

3022

G04.9

ICD-10 Finland

Encephalitis, myelitis and encephalomyelitis, unspecified

7.2

8.7

CA1ME

NOMESCO Finland

Ultrasound oculometry

3.7

8.7

N05BA01

ATC

diazepam; systemic, rectal

1.5

8.7

324

2300

EB4VA, ,

NOMESCO Finland

0.6

8.7

202

3053

207

Kela drug reimbursment

Chronic arrhythmias

0.6

8.7

217

3229

2312

FHL

Extirpation or destruction

50.1

8.7

ZZQ10

NOMESCO Finland

Free microvascular graft of skin and muscle

50.1

8.7

C43

ICD-10 Finland

Malignant melanoma of skin

50.1

8.7

Z08.8

ICD-10 Finland

Follow-up examination after other treatment for malignant neoplasm

50.1

8.7

OAA80, ,

SPAT

0.5

8.6

1602

JN5DR

NOMESCO Finland

PET-CT of upper body metabolism

6.6

8.6

FM2CE, ,

NOMESCO Finland

4.6

8.6

DFF20

NOMESCO Finland

Audiometry for children

11.6

8.6

I10

ICD-10 Finland

Essential (primary) hypertension

0.8

8.5

1364

15376

XX8XW, ,

NOMESCO Finland

16.3

8.5

R47.8

ICD-10 Finland

Other and unspecified speech disturbances

3.1

8.5

115

JN3KE

NOMESCO Finland

Abdominal ultrasound with added contrast

10.0

8.5

CKA10

NOMESCO Finland

Biopsy of vitreous body

10.0

8.5

9530/0-C70.9

ICD-O-3

Meningioma, NOS, of meninges, NOS

10.0

8.5

A04AA03

ATC

tropisetron; systemic

27.6

8.5

Z25.8

ICD-10 Finland

Need for immunization against other specified single viral diseases

0.6

8.4

115

1982

L04AX04

ATC

lenalidomide; oral

90.3

8.4

M05BA02

ATC

clodronic acid; systemic

90.3

8.4

1XC03, ,

NOMESCO Finland

90.3

8.4

2311

FHL

Resection

90.3

8.4

153

Kela drug reimbursment

Lenalidomid

90.3

8.4

CAB10

NOMESCO Finland

Lateral orbitotomy with excision of lesion

90.3

8.4

XKD00

NOMESCO Finland

Uroflowmetry

1.4

8.4

338

2434

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.5

8.4

231

1542

I63.9

ICD-10 Finland

Cerebral infarction, unspecified

1.5

8.4

312

2215

ZXC86

NOMESCO Finland

Use of endoscopic device

4.5

8.4

1929X

ICD-9 Finland

Malignant neoplasm of other and unspecified parts of nervous system, Nervous system, part unspecified

+∞

8.3

3016

Kela drug reimbursment

Binimetinib and encorafenib

+∞

8.3

C18.21

ICD-10 Finland

Malignant tumor of the ascending colon invasive carcinoma

+∞

8.3

AAA50

NOMESCO Finland

Intracranial endoscopy

+∞

8.3

L02BB04

ATC

enzalutamide; oral

+∞

8.3

1744A

ICD-9 Finland

Malignant neoplasm of female breast, Upper-outer quadrant

+∞

8.3

C44.81

ICD-10 Finland

Overall basocellular carcinoma of the skin

+∞

8.3

C77.3

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Axillary and upper limb lymph nodes

+∞

8.3

9445/3-C71.9

ICD-O-3

Glioblastoma, IDH-mutant of brain, NOS

+∞

8.3

AAF30

NOMESCO Finland

Implantation of intraventricular injection device

+∞

8.3

L02BX02

ATC

degarelix; parenteral

+∞

8.3

1501

Kela drug reimbursment

Palbociclib

+∞

8.3

C17.9

ICD-10 Finland

Malignant neoplasm: Small intestine, unspecified

+∞

8.3

Q85.1

ICD-10 Finland

Tuberous sclerosis

+∞

8.3

1XC07, ,

NOMESCO Finland

+∞

8.3

C69.91

ICD-10 Finland

Malignant tumor in unspecified localization in the eye retinoblastoma

+∞

8.3

167

Kela drug reimbursment

Dabrafenib, trametinib and vemurafenib

+∞

8.3

8000/3-C71.2

ICD-O-3

Neoplasm, malignant of temporal lobe

+∞

8.3

1513

Kela drug reimbursment

Binimetinib and encorafenib

+∞

8.3

HAC25

NOMESCO Finland

Radical mastectomy

+∞

8.3

L01XE04

ATC

[U] sunitinib

+∞

8.3

XX9CD

NOMESCO Finland

Very extensive complementary CT

+∞

8.3

ZX004, ,

NOMESCO Finland

+∞

8.3

D43.3

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Cranial nerves

+∞

8.3

C71.62

ICD-10 Finland

Malignant tumor of cerebellum grade III glioma

+∞

8.3

8140/3-C18.2

ICD-O-3

Adenocarcinoma, NOS, of ascending colon

+∞

8.3

YA1WD, ,

NOMESCO Finland

+∞

8.3

C71.5

ICD-10 Finland

Malignant neoplasm: Cerebral ventricle

+∞

8.3

8140/3-C34.3

ICD-O-3

Adenocarcinoma, NOS, of lower lobe, lung

+∞

8.3

1919X

ICD-9 Finland

Malignant neoplasm of brain, Brain, unspecified[TARKEMMIN MÄÄRITTELEMÄTÖN AIVOSYÖPÄ,EI HIST VAHV]

+∞

8.3

362

Kela drug reimbursment

Dabrafenib, trametinib and vemurafenib

+∞

8.3

8090/3-C44.2

ICD-O-3

Basal cell carcinoma, NOS, of external ear

+∞

8.3

C69.50

ICD-10 Finland

Malignant tumor of lacrimal gland and lacrimal duct without histology

+∞

8.3

C50.00

ICD-10 Finland

Malignant tumor of nipple and areola, no histological veryfication

+∞

8.3

C71.73

ICD-10 Finland

Malignant tumor of the brain stem grade IV glioma

+∞

8.3

8140/3-C18.7

ICD-O-3

Adenocarcinoma, NOS, of sigmoid colon

+∞

8.3

C73.99

ICD-10 Finland

Malignant tumor of the thyroid gland (thyroid gland), other or unspecified histology

+∞

8.3

C43.53

ICD-10 Finland

Malignant melanoma of the torso nodular

+∞

8.3

C25.9

ICD-10 Finland

Malignant neoplasm: Pancreas, unspecified

+∞

8.3

C71.41

ICD-10 Finland

Malignant tumor of occipital lobe grade II glioma

+∞

8.3

1BC01, ,

NOMESCO Finland

+∞

8.3

C80.90

ICD-10 Finland

Malignant tumor without specified localization without histology

+∞

8.3

N03AX16

ATC

[U] pregabalin

1.3

8.3

539

4200

QAE40

NOMESCO Finland

Repair of anomaly or lesion after disease of skin of head or neck

14.5

8.2

SPAT1109

SPAT

Analgesia with portable analgesic pump

7.5

8.1

M05BX04

ATC

denosumab; parenteral

1.8

8.1

118

668

ED1AA

NOMESCO Finland

Mandibular X-ray examination

4.5

8.1

PA6AD

NOMESCO Finland

CT of neck arteries

1.9

8.1

102

552

E89.30

ICD-10 Finland

Postprocedural hypopituitarism

33.4

8.1

D33.39

ICD-10 Finland

Benign tumor of the cranial nerves UNS

17.2

8.1

Z80.8

ICD-10 Finland

Family history of malignant neoplasm of other organs or systems

11.7

8.1

H02.4

ICD-10 Finland

Ptosis of eyelid

2.1

8.1

372

290

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

0.7

8.0

232

3353

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

1.6

8.0

192

1243

D48.9

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Neoplasm of uncertain or unknown behaviour, unspecified

2.8

8.0

142

NK6MA

NOMESCO Finland

Measurement of bone age from hand and elbow using X-ray

3.9

7.9

JN3BD

NOMESCO Finland

Extensive abdominal CT

1.6

7.8

195

1273

Z80.3

ICD-10 Finland

Family history of malignant neoplasm of breast

3.3

7.8

R01AD12

ATC

fluticasone furoate; nasal

0.7

7.8

477

6072

A10BA02

ATC

metformin; oral

0.8

7.8

507

6397

O99.3

ICD-10 Finland

Mental disorders and diseases of the nervous system complicating pregnancy, childbirth and the puerperium

3.0

7.8

111

ZX002

NOMESCO Finland

Simple dose design for radiotherapy based on tomography - isocentric therapy

45.1

7.7

8130/2-C67.9

ICD-O-3

Papillary urothelial carcinoma, non-invasive of bladder, NOS

45.1

7.7

Z03.1

ICD-10 Finland

Observation for suspected malignant neoplasm

3.1

7.7

TNE25

NOMESCO Finland

Drill biopsy of bone marrow, pelvis

4.5

7.6

JFB30

NOMESCO Finland

Right hemicolectomy

4.5

7.6

74340

ICD-8 Finland

Other congenital anomalies of nervous system, Neurofibromatosis

25.1

7.6

N80

ICPC

Head injury other

2.2

7.6

294

XX9AW

NOMESCO Finland

Production of copy from X-ray picture

2.0

7.6

395

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.6

7.6

160

1005

KCD05

NOMESCO Finland

Excision of bladder lesion during urinary tract endoscopy with photodynamic diagnosis (PDD)

10.0

7.5

M03BX01

ATC

baclofen; systemic

2.3

7.5

237

R74

ICPC

Upper respiratory infection acute

0.8

7.5

498

6274

ZXC50

NOMESCO Finland

Cryotherapy

2.3

7.5

225

Z50.5

ICD-10 Finland

Speech therapy

2.6

7.4

159

AA5GG

NOMESCO Finland

Extensive functional MRI examination of brain withhigh intensity magnet

80.3

7.4

C72.4

ICD-10 Finland

Malignant neoplasm: Acoustic nerve

80.3

7.4

D33.04

ICD-10 Finland

Temporal lobe

80.3

7.4

D42.9

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Meninges, unspecified

80.3

7.4

B72

ICPC

Hodgkin Lymphoma

80.3

7.4

ZX000

NOMESCO Finland

Simple adjustment of radiotherapy with simulator or with therapeutic device - isocentric therapy

80.3

7.4

KBJ10

NOMESCO Finland

Cutaneous ureteroenterostomy

80.3

7.4

PJD44

NOMESCO Finland

Excision of iliac lymph nodes

80.3

7.4

XX9AQ

NOMESCO Finland

Supplementary SPECT-CT or additional scan

80.3

7.4

XX4AW, ,

NOMESCO Finland

7.7

7.4

R07.4

ICD-10 Finland

Chest pain, unspecified

0.8

7.3

491

6181

NA3BG, ,

SPAT

0.3

7.3

617

351

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

0.7

7.3

206

2996

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

0.7

7.3

331

4416

1912X

ICD-9 Finland

Malignant neoplasm of brain, Temporal lobe[AIVOJEN OHIMOLOHKON SYÖPÄ,EI HISTOLOGISTA VAHVISTUS]

+∞

7.3

C50.19

ICD-10 Finland

Malignant tumor of the central part of the mammary gland, other or undeterminated histology

+∞

7.3

9382/3-C71.2

ICD-O-3

Oligoastrocytoma, NOS, of temporal lobe

+∞

7.3

C92.0

ICD-10 Finland

Acute myeloblastic leukaemia [AML]

+∞

7.3

C69.49

ICD-10 Finland

Malignant tumor of ciliary body other or unspecified histology

+∞

7.3

8140/3-C18.0

ICD-O-3

Adenocarcinoma, NOS, of cecum

+∞

7.3

343

Kela drug reimbursment

Pazopanib

+∞

7.3

C43.90

ICD-10 Finland

Unspecified localization of malignant melanoma of the skin without histology

+∞

7.3

1990X

ICD-9 Finland

Malignant neoplasm without specification of site, Disseminated

+∞

7.3

394

Kela drug reimbursment

Palbociclib

+∞

7.3

C43.30

ICD-10 Finland

Malignant melanoma of another or unspecified part of the face without histology

+∞

7.3

C50.20

ICD-10 Finland

Malignant tumor of the upper inner quadrant of the mammary gland,no histological veryfication

+∞

7.3

C43.39

ICD-10 Finland

Malignant melanoma of another or unspecified part of the face other or unspecified histology

+∞

7.3

C34.16

ICD-10 Finland

Malignant tumor of the anterior, bronchial or pulmonary microcellular carcinoma

+∞

7.3

C79.40

ICD-10 Finland

Secondary malignant tumor of the spinal cord

+∞

7.3

1911A

ICD-9 Finland

Malignant neoplasm of brain, Frontal lobe[AIVOJEN OTSALOHKON SYÖPÄ,ASTROCYTOMA (GR I-II)]

+∞

7.3

YN1AD

NOMESCO Finland

CT examination of extremities for dose design of radiotherapy

+∞

7.3

1509

Kela drug reimbursment

Dabrafenib (adjuvant treatment)

+∞

7.3

C69.4

ICD-10 Finland

Malignant neoplasm: Ciliary body

+∞

7.3

C34.30

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung without histology

+∞

7.3

19251

ICD-8 Finland

Malignant neoplasm of other part of nervous system, Sympathetic nervous system

+∞

7.3

C18.01

ICD-10 Finland

Malignant tumor of the caecum invasive carcinoma

+∞

7.3

KCC10

NOMESCO Finland

Cystoprostatectomy

+∞

7.3

C75.3

ICD-10 Finland

Malignant neoplasm: Pineal gland

+∞

7.3

C83.89

ICD-10 Finland

Other types of diffuse non-Hodgkin's lymphoma

+∞

7.3

C20.92

ICD-10 Finland

Malignant tumor of the rectum carcinoma of the adenoma

+∞

7.3

3024

Kela drug reimbursment

Dabrafenib and trametinib (adjuvant treatment)

+∞

7.3

C71.04

ICD-10 Finland

Malignant tumor of the cerebrum except lobes and ventricles ependyoma

+∞

7.3

1920A

ICD-9 Finland

Malignant neoplasm of other and unspecified parts of nervous system, Cranial nerves

+∞

7.3

9680/3-C77.9

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of lymph node, NOS

+∞

7.3

C69.89

ICD-10 Finland

Overall malignant tumor of the eye and adnexa other or unspecified histology

+∞

7.3

9591/3-C69.9

ICD-O-3

Malignant lymphoma, non-Hodgkin, NOS, of eye, NOS

+∞

7.3

L01XE23

ATC

[U] dabrafenib

+∞

7.3

9400/3-C71.3

ICD-O-3

Astrocytoma, NOS, of parietal lobe

+∞

7.3

C78.8

ICD-10 Finland

Secondary malignant neoplasm of other and unspecified digestive organs

+∞

7.3

C69.53

ICD-10 Finland

Malignant tumor of lacrimal gland and tear duct carcinoma

+∞

7.3

C56

ICD-10 Finland

Malignant neoplasm of ovary

+∞

7.3

8720/3-C44.7

ICD-O-3

Malignant melanoma, NOS, of skin of lower limb and hip

+∞

7.3

XX7JT

NOMESCO Finland

Somatostatin isotope ablative therapy

+∞

7.3

QX2AN

NOMESCO Finland

Other soft tissue tumour isotope imaging

+∞

7.3

C18.2

ICD-10 Finland

Malignant neoplasm: Ascending colon

+∞

7.3

L03AB04

ATC

interferon alfa-2a; parenteral

+∞

7.3

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

2.1

7.3

332

NA2BG

NOMESCO Finland

Thoracal spine MRI examination with high intensity magnet

2.2

7.3

279

L08

ICPC

Shoulder symptom/complaint

0.7

7.3

362

4760

R1220

NOMESCO Finland

Psychological examination of need and possibilities to rehabilitation

3.3

7.2

WZC30, ,

SPAT

0.6

7.2

1626

9539/1-C70.9

ICD-O-3

Atypical meningioma of meninges, NOS

30.1

7.1

AWW99

NOMESCO Finland

Other reoperation in surgery of the nervous system

30.1

7.1

C07AB07

ATC

bisoprolol; oral

0.8

7.1

1018

11704

M16.0

ICD-10 Finland

Primary coxarthrosis, bilateral

0.5

7.1

1368

2377A

ICD-9 Finland

Neoplasm of uncertain behaviour of endocrine glands and nervous system, Neurofibromatosis

20.1

7.1

GDC00

NOMESCO Finland

Lobectomy of lung

20.1

7.1

1CX01, ,

NOMESCO Finland

20.1

7.1

S01ED51

ATC

timolol, combinations; ophthalmic

1.5

7.1

199

1334

N06DA02

ATC

donepezil; oral

0.5

7.1

1261

8000/0-C70.0

ICD-O-3

Neoplasm, benign of cerebral meninges

6.0

7.1

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

1.9

7.0

441

F43.29

ICD-10 Finland

Adaptation disorder UNS

2.2

7.0

251

QXA25

NOMESCO Finland

Destruction of lesion of skin, site unspecified

2.4

7.0

182

Y83.8

ICD-10 Finland

Other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.2

6.9

265

GD5BD

NOMESCO Finland

Thorax and upper abdomen combined extensive CT examination of

2.7

6.9

130

KAC11

NOMESCO Finland

Total nephrectomy with capsule, transcutaneous

13.8

6.9

Z63.7

ICD-10 Finland

Other stressful life events affecting family and household

2.5

6.8

166

Z31.6

ICD-10 Finland

General counselling and advice on procreation

3.5

6.8

M54.4

ICD-10 Finland

Lumbago with sciatica

0.7

6.8

249

3448

S01EA03

ATC

apraclonidine; ophthalmic

3.0

6.8

N95.1

ICD-10 Finland

Menopausal and female climacteric states

0.6

6.8

102

1712

K22

ICPC

Risk factor cardiovascular disease

0.5

6.8

1043

H33.2

ICD-10 Finland

Serous retinal detachment

6.1

6.8

E89.4

ICD-10 Finland

Postprocedural ovarian failure

40.1

6.8

DAB10

NOMESCO Finland

Partial excision of auricle

40.1

6.8

JLC30

NOMESCO Finland

Pancreatoduodenectomy

40.1

6.8

CKE40

NOMESCO Finland

Transpupillary photocoagulation of lesion of retina

40.1

6.8

D33.47

ICD-10 Finland

Other benign neurofibromas in the nerve root of the spinal cord

40.1

6.8

WPA43, ,

SPAT

16.7

6.7

M17.0

ICD-10 Finland

Primary gonarthrosis, bilateral

0.7

6.7

193

2796

QX4AT

NOMESCO Finland

Ultrsound guided needle biopsy of skin

7.2

6.7

D37.6

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Liver, gallbladder and bile ducts

3.2

6.7

A41.9

ICD-10 Finland

Sepsis, unspecified

1.9

6.7

463

XX9CW

NOMESCO Finland

Submitting image material and/or investigation material to patient

3.3

6.7

L01AA02

ATC

chlorambucil; oral

22.6

6.7

PH7FT

NOMESCO Finland

Inmplantation of filter to inferior vena cava with radiological guidance

22.6

6.7

C44.71

ICD-10 Finland

Basocellular carcinoma of the skin of the lower extremity including the hip

22.6

6.7

WD315

NOMESCO Finland

Multiple therapy of methastized malignancy with biomodifiers

22.6

6.7

E87.0

ICD-10 Finland

Hyperosmolality and hypernatraemia

3.7

6.6

H05.2

ICD-10 Finland

Exophthalmic conditions

7.8

6.6

XCD20

NOMESCO Finland

Photoangiography of eye

2.3

6.6

206

QAA05

NOMESCO Finland

Incision for biopsy of skin of head or neck

2.6

6.5

146

NA3DG

NOMESCO Finland

Lumbar spine very extensive MRI examination with high intensity magnet

3.7

6.5

R5110, ,

SPAT

1.5

6.5

206

1420

Y83.9

ICD-10 Finland

Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.0

6.4

314

T81.8

ICD-10 Finland

Other complications of procedures, not elsewhere classified

2.4

6.4

165

WX1DG

NOMESCO Finland

Very extensive total body MRI with high intensity magnet

70.0

6.4

I97.2

ICD-10 Finland

Postmastectomy lymphoedema syndrome

70.0

6.4

AA5AK

NOMESCO Finland

Brain spectroscopy

70.0

6.4

C20.99

ICD-10 Finland

Malignant tumor of the rectum other or unspecified histology

70.0

6.4

HA1CG

NOMESCO Finland

Extensive MRI examination of mammary gland with high intensity magnet

7.4

6.4

NK6CT

NOMESCO Finland

Bone biopsy with CT guidance

14.3

6.4

E11

ICD-10 Finland

Type 2 diabetes mellitus

0.7

6.4

224

3125

SDA03

NOMESCO Finland

Periodontal treatment

0.8

6.4

716

8473

H35.9

ICD-10 Finland

Retinal disorder, unspecified

3.7

6.4

I67.6

ICD-10 Finland

Nonpyogenic thrombosis of intracranial venous system

8.2

6.3

JDB10

NOMESCO Finland

Percutaneous gastrostomy

3.1

6.3

RS121, ,

NOMESCO Finland

3.6

6.3

KAD01

NOMESCO Finland

Percutaneous endoscopic partial nephrectomy

11.0

6.3

301

Kela drug reimbursment

Growth hormone

11.0

6.3

WPA45

NOMESCO Finland

Continuous drug infusion in palliative care

11.0

6.3

G71.9

ICD-10 Finland

Primary disorder of muscle, unspecified

9.3

6.3

SAA02

NOMESCO Finland

Basic examination of mouth

0.8

6.3

1415

15615

XW4AT

NOMESCO Finland

Biopsy of other inner organ with ultrasound guidance

18.0

6.3

1AC01, ,

NOMESCO Finland

+∞

6.2

8500/3-C50.1

ICD-O-3

Infiltrating duct carcinoma, NOS, of central portion of breast

+∞

6.2

8380/3-C54.9

ICD-O-3

Endometrioid adenocarcinoma, NOS, of corpus uteri

+∞

6.2

C76.0

ICD-10 Finland

Malignant neoplasm of other and ill-defined sites: Head, face and neck

+∞

6.2

WC305

NOMESCO Finland

Simple therapy of local tumor recidive with biomodifiers

+∞

6.2

192

Kela drug reimbursment

Fulvestrant

+∞

6.2

AA049

NOMESCO Finland

Radiotherapy of metasthasis in the brain

+∞

6.2

L01BC59

ATC

trifluridine, combinations; systemic

+∞

6.2

C44.29

ICD-10 Finland

Malignant tumor of the skin of the outer ear and in the outer ear canal other or unspecified histology

+∞

6.2

L02BA03

ATC

fulvestrant; parenteral

+∞

6.2

WB402

NOMESCO Finland

Demanding antibody therapy of primary tumour

+∞

6.2

WB111

NOMESCO Finland

Multiple neoadjuvant cytostatic therapy

+∞

6.2

9382/3-C71.3

ICD-O-3

Oligoastrocytoma, NOS, of parietal lobe

+∞

6.2

C81.1

ICD-10 Finland

Nodular sclerosis classical Hodgkin lymphoma

+∞

6.2

9445/3-C71.1

ICD-O-3

Glioblastoma, IDH-mutant of frontal lobe

+∞

6.2

9401/3-C71.3

ICD-O-3

Astrocytoma, anaplastic, NOS, of parietal lobe

+∞

6.2

C71.05

ICD-10 Finland

Malignant tumor of the cerebrum except lobes and ventricles primary neuroectodermal tumor

+∞

6.2

C50.89

ICD-10 Finland

Overall malignant tumor of the mammary gland, other or undeterminated histology

+∞

6.2

C50.1

ICD-10 Finland

Malignant neoplasm: Central portion of breast

+∞

6.2

C34.86

ICD-10 Finland

Malignant overall tumor of bronchial and pulmonary microcellular carcinoma

+∞

6.2

8410/3-C44.1

ICD-O-3

Sebaceous carcinoma of eyelid

+∞

6.2

1911F

ICD-9 Finland

Malignant neoplasm of brain, Frontal lobe[AIVOJEN OTSALOHKON SYÖPÄ,MUU]

+∞

6.2

C78.2

ICD-10 Finland

Secondary malignant neoplasm of pleura

+∞

6.2

9823/3-C42.1

ICD-O-3

B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma of bone marrow

+∞

6.2

Z92.6

ICD-10 Finland

Personal history of chemotherapy for neoplastic disease

+∞

6.2

C77.2

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Intra-abdominal lymph nodes

+∞

6.2

2141

FHL

Stereotactic biopsy of the brain

+∞

6.2

8140/3-C19.9

ICD-O-3

Adenocarcinoma, NOS, of rectosigmoid junction

+∞

6.2

C74.1

ICD-10 Finland

Malignant neoplasm: Medulla of adrenal gland

+∞

6.2

198

Kela drug reimbursment

Sorafenib

+∞

6.2

1921A

ICD-9 Finland

Malignant neoplasm of other and unspecified parts of nervous system, Cerebral meninges

+∞

6.2

ZXC21, ,

NOMESCO Finland

+∞

6.2

C82.00

ICD-10 Finland

Follicular nodular non-Hodgkin's lymphoma, ungraded

+∞

6.2

C43.9

ICD-10 Finland

Malignant neoplasm: Malignant melanoma of skin, unspecified

+∞

6.2

YX8CD

NOMESCO Finland

Stereotactic very extensive CT examination for dose design of radiotherapy

+∞

6.2

19105

ICD-8 Finland

Malignant neoplasm of brain, Hypothalami

+∞

6.2

C79.0

ICD-10 Finland

Secondary malignant neoplasm of kidney and renal pelvis

+∞

6.2

C71.66

ICD-10 Finland

Malignant tumor of the cerebellum medullobastoma

+∞

6.2

Z08.1

ICD-10 Finland

Follow-up examination after radiotherapy for malignant neoplasm

+∞

6.2

9424/3-C71.9

ICD-O-3

Pleomorphic xanthoastrocytoma, NOS, of brain, NOS

+∞

6.2

8010/3-C80.9

ICD-O-3

Carcinoma, NOS, of unknown primary site

+∞

6.2

C50.92

ICD-10 Finland

Malignant tumor in another specified localization in lobular gland, lobular tumor

+∞

6.2

C74.0

ICD-10 Finland

Malignant neoplasm: Cortex of adrenal gland

+∞

6.2

AAF45

NOMESCO Finland

Fenestration of intracranial cyst

+∞

6.2

AX099

NOMESCO Finland

Radiotherapy of whole central nervous system

+∞

6.2

C43.79

ICD-10 Finland

Malignant melanoma of the lower extremity including hip or other unspecified histology

+∞

6.2

M17

ICD-10 Finland

Gonarthrosis [arthrosis of knee]

0.6

6.2

127

1978

L03AA04, ,

ATC

26.7

6.2

PJD81

NOMESCO Finland

Excision of lymph nodes from upper part of neck

26.7

6.2

2251A

ICD-9 Finland

Benign neoplasm of brain and other parts of nervous system, Cranial nerves

26.7

6.2

D33.1

ICD-10 Finland

Benign neoplasm: Brain, infratentorial

26.7

6.2

R84

ICPC

Malignant neoplasm bronchus/lung

26.7

6.2

3314A

ICD-9 Finland

Other cerebral degenerations, Obstructive hydrocephalus

26.7

6.2

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

1.7

6.2

571

C03CA01

ATC

furosemide; systemic

1.2

6.2

804

6822

SPAT1137

SPAT

Taking care of patient’s/customer’s hygiene

1.6

6.2

143

920

HA1TE

NOMESCO Finland

Supplementary or limited ultrasound examination of mammary glands

6.3

6.2

G83.9

ICD-10 Finland

Paralytic syndrome, unspecified

7.7

6.1

G40.00

ICD-10 Finland

Benign childhood epilepsy with centrotemporal EEG spikes

7.7

6.1

R1250

NOMESCO Finland

Evaluation of functional capability

1.9

6.1

348

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.3

6.1

681

5680

SDA04

NOMESCO Finland

Demanding periodontal treatment

0.8

6.1

466

5779

A10AB05

ATC

insulin aspart; parenteral

1.5

6.1

196

1354

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.3

6.1

653

5422

KEB00

NOMESCO Finland

Biopsy of prostate

3.8

6.1

R42

ICD-10 Finland

Dizziness and giddiness

1.3

6.1

579

4741

9101

FHL

Bone biopsy

8.6

6.0

D04.3

ICD-10 Finland

Carcinoma in situ: Skin of other and unspecified parts of face

2.6

6.0

128

WPA44

NOMESCO Finland

Nursing home for palliative care

10.0

6.0

G91.8

ICD-10 Finland

Other hydrocephalus

10.0

6.0

ZXE02

NOMESCO Finland

Procedure duration 10 to 19 minutes

1.7

6.0

561

R053, ,

ICD-10 Finland

0.3

6.0

491

D48.1

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Connective and other soft tissue

2.2

6.0

202

HAB99

NOMESCO Finland

Other partial excision of mammary gland

3.5

6.0

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(4035726) Immunohistochemistry procedure

1075

682

23.60

307.65

1.4

1.3

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

179

70.28

307.65

1.1

1.2

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

419

133

36.26

307.65

1.8

2.0

—

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

271

+∞

287.01

1.0

0.0

—

(3003396) Base excess in Arterial blood by calculation

910

2878

4.06

250.75

7.8

8.3

1.11

mmol/l

0.01

727

2360

(3019977) pH of Arterial blood

910

2886

4.05

249.65

7.9

8.4

7.42

1.02

581

1626

(3027801) Oxygen [Partial pressure] in Arterial blood

910

2897

4.03

248.15

7.9

8.3

16.60

11.72

kpa

78.26

876

2785

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

910

2897

4.03

248.15

7.9

8.4

5.01

5.09

kpa

2.17

875

2784

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

131

54.66

230.49

1.5

1.2

—

(3018677) aPTT in Platelet poor plasma by Coagulation assay

1039

3844

3.56

223.54

2.2

27.73

29.73

21.69

1013

3741

(40768804) Tissue Pathology biopsy report

1578

7840

3.06

202.03

2.9

1.7

—

(3044640) Blood type and Crossmatch panel - Blood

1444

7149

2.91

180.79

2.8

2.2

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

703

2302

3.66

178.22

5.8

2.6

239.98

232.33

u/l

0.94

686

2152

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

214

248

9.19

171.07

2.0

1.4

—

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

159

+∞

167.20

1.1

0.0

—

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

1999

12101

2.84

164.64

13.2

4.1

10.48

12.12

umol/l

9.31

1963

11391

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

317

601

5.76

161.23

2.0

1.4

2200.73

1274.55

e6/l

0.58

251

481

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

313

592

5.77

159.56

1.9

1.3

48.92

26.38

e6/l

0.57

239

448

(3016018) Differential panel - Cerebral spinal fluid

213

279

8.12

154.00

1.8

1.3

—

(3033658) Prothrombin time (PT) actual/Normal

1222

5921

2.76

153.76

4.6

3.9

93.04

87.96

11.76

1191

5785

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

329

676

5.32

152.95

1.8

1.3

990.11

513.96

mg/l

2.18

323

640

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

1836

11044

2.62

146.22

9.1

6.3

1.20

1.21

mmol/l

11.66

1774

10069

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

1129

5449

2.69

140.71

2.7

2.2

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

137

113

12.64

138.51

2.5

2.4

55.90

53.98

umol/l

0.19

122

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

1950

12419

2.54

132.16

9.8

6.5

1.20

1.21

mmol/l

9.71

1730

10680

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

288

601

5.18

131.08

1.7

1.2

3.58

3.83

mmol/l

2.66

278

569

(3013650) Neutrophils [#/volume] in Blood by Automated count

2036

13520

2.47

121.29

18.7

6.9

4.10

4.26

e9/l

2.20

1788

11541

(3002173) Hemoglobin [Mass/volume] in Arterial blood

620

2385

3.00

116.41

9.3

125.93

122.78

g/l

3.62

603

2335

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

1686

10569

2.30

110.65

3.3

2.5

—

estimate

—

(3012095) Magnesium [Moles/volume] in Serum or Plasma

828

3792

2.61

110.63

4.3

3.0

0.83

0.82

mmol/l

0.66

796

3522

(3016502) Oxygen saturation in Arterial blood

643

2594

2.87

110.15

9.2

8.7

97.32

95.12

19.95

623

2504

(3013826) Glucose [Moles/volume] in Serum or Plasma

2142

14890

2.42

109.80

8.5

4.9

6.73

6.75

mmol/l

0.19

2093

14079

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

119

123

10.02

103.24

1.8

1.7

—

(3014007) Fractional oxyhemoglobin in Arterial blood

452

1601

3.13

96.91

8.2

11.0

95.44

93.46

10.45

452

1594

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

137

192

7.42

93.01

1.8

1.2

2.47

2.23

mmol/l

0.68

129

181

(40768795) Lymph node Pathology biopsy report

19.37

92.02

1.3

1.1

—

(3019069) Monocytes/Leukocytes in Blood

1731

11497

2.14

91.79

10.5

6.2

8.96

8.91

0.31

1683

10706

(3011412) CD3 cells [#/volume] in Blood

125

160

8.10

91.75

2.2

1049.79

1300.89

e6/l

2.00

113

139

(3006504) Eosinophils/Leukocytes in Blood

1724

11477

2.13

90.30

10.4

6.1

2.20

2.95

36.96

1672

10685

(3022096) Basophils/Leukocytes in Blood

1721

11493

2.12

88.85

10.4

6.2

0.56

0.67

15.75

1672

10688

(3023368) Bacteria identified in Blood by Culture

1152

6644

2.17

87.00

5.2

4.0

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

1315

7989

2.12

86.64

8.0

2.1

2.35

mmol/l

0.01

1247

7077

(3024561) Albumin [Mass/volume] in Serum or Plasma

1624

10681

2.09

86.48

6.3

4.2

34.86

35.90

g/l

10.42

1552

9884

(3023410) Appearance of Cerebral spinal fluid

153

261

6.11

86.13

2.0

1.5

—

(3002030) Lymphocytes/Leukocytes in Blood

1738

11752

2.09

85.52

10.7

6.1

24.43

27.84

30.75

1696

11089

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

103

117

9.07

83.18

2.2

2.0

—

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

1358

8461

2.08

82.53

2.8

2.2

175.85

224.15

u/l

1.52

1326

7983

(3001604) Monocytes [#/volume] in Blood

1820

12634

2.07

81.94

10.3

5.9

0.58

0.59

e9/l

1.95

1564

10793

(3036481) Cortisol [Moles/volume] in Serum or Plasma

540

2296

2.64

81.52

3.0

1.9

342.43

372.20

nmol/l

1.25

517

2102

(3018010) Neutrophils/Leukocytes in Blood

1707

11593

2.05

81.45

10.3

6.0

60.24

57.27

18.59

1674

11020

(3006315) Basophils [#/volume] in Blood

1820

12678

2.05

80.60

10.3

5.9

0.03

0.04

e9/l

19.26

1564

10835

(1175426) CD3 cells/Lymphocytes in Blood

103

127

8.35

77.92

2.1

2.0

73.13

72.17

0.20

121

(3019198) Lymphocytes [#/volume] in Blood

1833

12925

2.02

76.93

10.5

6.0

1.66

1.89

e9/l

5.16

1592

11301

(3018418) pH of Serum or Plasma

1189

7235

2.04

75.32

5.1

3.4

7.40

3.84

854

5150

(3013115) Eosinophils [#/volume] in Blood

1845

13106

2.01

75.01

11.0

6.1

0.14

0.20

e9/l

42.74

1596

11361

(3019779) Phenytoin [Moles/volume] in Serum or Plasma

17.75

74.91

6.6

4.8

45.94

40.68

umol/l

0.58

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

360

1348

2.89

68.86

11.3

11.7

16.77

16.09

4.22

341

1302

(3000991) Gas panel - Venous blood

501

2219

2.50

68.62

8.5

9.7

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

329

1177

3.01

68.31

3.3

1.5

22.89

2.71

ug/l

0.77

254

873

(3032080) INR in Blood by Coagulation assay

1655

11571

1.92

67.62

10.9

16.9

1.16

1.31

inr

28.02

1426

9689

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

8.75

60.75

3.3

2.7

28.28

30.23

umol/l

0.64

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

2149

25158

0.52

55.11

4.9

6.0

2.74

2.68

mmol/l

2.54

1985

23493

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

664

10931

0.50

53.47

1.9

1.35

1.37

mmol/l

0.15

575

9255

(3045142) Bone marrow Pathology biopsy report

111

7.28

53.41

1.3

1.2

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

2110

24787

0.53

53.34

4.4

5.2

4.64

4.58

mmol/l

2.06

1950

23220

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

2318

18784

1.93

53.26

15.5

5.9

77.87

77.18

u/l

0.29

2258

17580

(3033306) Mononuclear cells/Leukocytes in Cerebral spinal fluid

119

6.96

52.59

2.1

1.2

61.66

53.75

0.42

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

120

6.90

52.19

2.3

2.2

165.39

228.15

e6/l

1.88

103

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

121

6.85

51.79

2.2

514.36

490.59

e6/l

0.13

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

2097

24631

0.54

51.74

4.3

5.2

1.43

1.44

mmol/l

0.36

1940

22917

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

134

6.41

50.45

1.2

1.1

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

471

2302

2.23

50.45

7.6

8.3

1.37

1.39

mmol/l

0.18

462

2253

(3020779) Urea [Moles/volume] in Serum or Plasma

464

2284

2.21

48.72

5.6

7.7

7.55

10.28

mmol/l

15.60

440

2184

(3032352) Blasts [#/volume] in Cerebral spinal fluid

69.83

48.19

1.3

1.1

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

2019

23845

0.56

47.77

5.7

6.6

39.02

39.64

mmol/mol

2.62

1888

22372

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

8.41

47.57

1.9

1.1

22.36

31.44

—

(3014037) CD3+CD4+ (T4 helper) cells/cells in Blood

7.42

46.22

3.1

2.7

39.81

46.53

1.88

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

709

4178

1.90

45.03

2.1

1.8

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

134

6.02

44.65

1.1

2.01

1.09

u/l

1.54

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

145

409

3.67

43.95

4.0

6.1

468.96

547.20

iu/ml

0.09

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

121

6.24

43.39

1.2

1.1

—

(3003694) ABO and Rh group [Type] in Blood

994

6566

1.76

43.08

1.3

1.4

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

763

4677

1.84

42.47

4.4

2.1

2.45

2.44

mmol/l

0.97

705

4093

(21494814) CD8 cells/Lymphocytes in Specimen

8.94

41.95

1.8

1.9

37.35

25.34

4.90

(3021589) Normoblasts [#/volume] in Blood

1488

11047

1.67

41.31

18.7

10.1

0.00

e9/l

1.41

1191

8986

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

560

3164

1.94

39.87

2.0

1.8

—

(3030467) Casts [#/volume] in Urine by Automated count

1019

6897

1.71

39.80

3.4

3.1

0.46

0.40

e6/l

0.25

772

5013

(3009466) Valproate [Moles/volume] in Serum or Plasma

139

409

3.51

39.53

3.4

5.6

348.58

358.01

umol/l

0.32

130

362

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

146

445

3.39

39.31

3.0

2.1

32.08

25.24

u/ml

0.19

128

353

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

534

2986

1.95

39.13

2.0

1.8

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

103

251

4.21

38.29

1.1

—

(3004809) Band form neutrophils/Leukocytes in Blood

107

269

4.08

38.16

3.4

2.3

1.95

1.18

1.05

226

(3017181) Myelocytes/Leukocytes in Blood

408

2093

2.09

37.98

5.3

4.1

1.54

0.71

9.45

227

433

(36304419) Bacteria [Presence] in Urine

974

6578

1.70

37.98

3.4

3.1

0.00

346.28

estimate

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

2024

23530

0.60

37.96

3.8

4.4

1.30

mmol/l

0.05

1871

21669

(3019060) Gas panel - Arterial blood

324

1521

2.26

37.72

9.2

4.8

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

210

4.43

36.30

1.5

1.2

—

(3039000) Anion gap in Blood by calculation

147

479

3.17

35.50

14.2

7.4

10.77

11.59

mmol/l

2.41

128

430

(3018572) Chloride [Moles/volume] in Blood

147

480

3.16

35.38

14.2

7.4

105.70

105.02

mmol/l

0.65

128

431

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1152

8252

1.63

35.09

5.1

2.8

31.98

36.95

u/l

1.05

1109

7751

(3002582) Erythrocytes [#/volume] in Urine

1132

8078

1.63

34.99

3.4

3.3

30.90

74.57

e6/l

3.27

875

6123

(3008152) Bicarbonate [Moles/volume] in Arterial blood

329

1605

2.17

34.75

12.4

6.7

25.23

24.47

mmol/l

3.30

307

1540

(40758558) Short blood count panel - Blood

1035

7260

1.64

34.07

13.0

4.9

—

(3026782) Osmolality of Urine

730

4705

1.72

33.02

3.2

2.8

524.98

533.65

mosm/kgh2o

0.54

662

4107

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

8.37

32.98

4.9

2.2

1.91

1.07

1.23

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

182

4.48

32.50

1.1

551.94

265.33

mg/l

1.50

158

(3005719) IgG [Mass/volume] in Serum or Plasma

346

1771

2.07

32.15

3.2

2.4

8.87

10.66

g/l

13.73

322

1635

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

193

4.34

31.91

1.2

79.30

37.83

mg/l

1.25

159

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

105

5.71

31.76

1.1

655.68

150.62

ng/l

0.62

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

185

732

2.62

31.27

3.1

4.2

0.40

0.34

iu/ml

0.87

100

419

(3021879) Hepatitis B virus core Ab [Presence] in Serum

324

1644

2.08

30.77

1.4

1.5

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

221

970

2.38

29.94

2.0

2.3

533.96

718.62

ug/l

0.30

209

919

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

110

336

3.36

29.53

5.9

6.8

9.78

11.94

mg/l

5.56

104

311

(3002179) Metamyelocytes/Leukocytes in Blood

371

2007

1.96

29.42

5.0

3.9

1.15

0.50

4.59

198

425

(3026008) Bacteria identified in Urine by Culture

1016

7299

1.58

29.28

3.3

3.2

—

(3002256) Pathology report gross observation

366

1984

1.96

28.83

1.4

1.1

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

168

660

2.63

28.80

1.9

1.7

—

(4027681) Cerebrospinal fluid IgG ratio and IgG index

142

4.73

28.73

1.4

1.2

0.49

0.53

ratio

0.80

(3021440) Promyelocytes/Leukocytes in Blood

370

2039

1.92

27.71

5.4

4.2

0.22

0.05

4.53

190

378

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

216

3.87

27.46

3.6

2.6

17.56

19.07

nmol/l

0.58

198

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

2142

24107

0.64

27.12

4.7

5.2

5.91

5.99

mmol/l

2.18

1965

22129

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

5.77

26.77

1.3

1.1

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

177

4.14

26.51

1.1

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

263

1303

2.11

26.50

1.5

—

(3003458) Phosphate [Moles/volume] in Serum or Plasma

523

3259

1.73

26.06

5.5

6.0

1.02

1.05

mmol/l

0.98

491

3003

(3007930) Methemoglobin/Hemoglobin.total in Blood

221

1035

2.22

25.66

12.1

5.2

0.98

0.86

4.67

203

974

(3008757) Leukocyte morphology finding [Identifier] in Blood

170

4.13

25.34

3.7

2.6

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

594

3870

1.66

24.95

3.0

2.26

2.47

e6/l

0.21

291

1836

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

233

1136

2.14

24.45

11.8

4.9

1.55

1.62

0.66

215

1075

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

121

4.69

24.28

1.1

—

(3000060) B lymphocytes [#/volume] in Blood

6.92

24.18

2.4

2.2

0.33

0.32

e9/l

0.04

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

220

3.61

23.70

1.7

1.3

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

197

3.77

23.66

2.8

2.7

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

428

2592

1.76

23.42

1.6

—

(1761868) Lipid panel - Serum or Plasma

689

9583

0.64

22.99

3.0

3.2

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

429

2613

1.74

22.98

2.9

2.4

7.16

7.67

umol/l

0.25

365

2257

(3018095) Leukocytes [#/volume] in Urine

1197

9268

1.47

22.84

4.1

3.8

54.99

100.22

e6/l

3.25

885

6414

(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay

30.27

22.76

7.0

1.0

91.35

17.45

u/ml

—

(3047181) Lactate [Moles/volume] in Blood

168

738

2.35

22.68

13.1

6.0

1.62

1.36

mmol/l

1.23

145

653

(3031040) Bacteria [#/volume] in Urine by Automated count

1899

16090

1.46

22.46

5.1

4.5

2199.50

1947.09

e6/l

0.05

242

(3012501) Base excess in Blood by calculation

124

475

2.68

22.37

3.8

4.4

2.34

2.58

mmol/l

0.43

303

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

630

4283

1.59

21.96

2.9

1.08

1.18

e6/l

0.21

330

2261

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

138

564

2.51

21.83

1.9

1.4

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

281

1529

1.92

21.69

1.7

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

103

367

2.87

21.33

2.0

1.4

—

(3012516) Albumin [Mass/volume] in Urine

653

9076

0.64

21.28

3.2

3.5

63.56

46.42

mg/l

1.09

435

5866

(3023183) Ammonium ion [Moles/volume] in Plasma

129

518

2.55

21.18

1.9

2.9

32.35

36.36

umol/l

0.86

115

472

(3036489) Thrombin time

188

899

2.16

20.70

2.3

2.2

21.45

20.88

0.55

172

804

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

125

500

2.56

20.69

1.5

1.7

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

499

3258

1.63

20.42

1.6

1.7

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

321

2.96

20.41

1.2

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

131

543

2.47

20.12

1.9

1.4

—

(3009508) Creatinine [Moles/volume] in Urine

712

9635

0.66

20.08

3.2

3.5

7.72

7.64

mmol/l

0.18

597

8177

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

5.91

19.15

1.3

1.4

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

109

425

2.62

19.02

1.4

1.5

—

(3020682) Albumin/Creatinine [Ratio] in Urine

681

9215

0.67

18.89

3.9

4.2

11.35

8.38

mg/mmol

0.96

434

5797

(3025159) Blasts/Leukocytes in Blood

344

2088

1.73

18.47

5.6

4.3

0.09

0.01

2.20

160

358

(3042936) Bacteria identified in Isolate by Culture

510

3431

1.58

18.27

2.0

2.1

—

(3008295) Osmolality of Serum or Plasma

281

2.93

17.65

1.6

1.5

283.22

279.45

mosm/kgh2o

0.70

211

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

384

2435

1.66

17.47

4.5

3.2

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

284

2.86

16.74

2.0

1.5

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

282

1663

1.76

16.72

1.9

1.6

—

(40768800) Prostate Pathology biopsy report

119

3.99

16.72

1.3

1.2

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

157

761

2.12

16.72

2.2

2.9

—

(3037121) Protein [Mass/volume] in Urine

168

836

2.07

16.69

5.5

3.3

183.64

428.30

mg/l

2.26

121

323

(3000850) Epithelial cells [#/volume] in Urine

751

5591

1.45

16.41

3.0

2.6

5.25

5.37

e6/l

0.08

699

5070

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

14.32

16.29

1.5

2.3

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

180

932

1.99

16.03

2.0

1.7

1.02

1.62

ug/l

0.83

155

815

(3003181) Sodium [Moles/volume] in Urine

111

480

2.36

15.59

1.4

82.08

60.80

mmol/l

4.28

103

388

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

194

3.19

15.47

1.9

1.4

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

136

644

2.16

15.39

2.3

1.5

7.47

8.07

u/l

0.25

107

506

(3021447) Carbon dioxide [Partial pressure] in Venous blood

411

2731

1.58

15.36

5.2

3.8

5.72

5.84

kpa

1.97

401

2648

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

314

1959

1.67

15.14

2.1

2.2

0.22

0.21

g/l

3.04

289

1794

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

146

718

2.08

14.99

1.4

1.3

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

121

3.76

14.76

1.2

1.1

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

+∞

14.59

1.2

0.0

—

(3002032) Base excess in Venous blood by calculation

400

2675

1.57

14.50

5.3

3.8

2.01

1.83

mmol/l

0.62

352

2327

(3009595) Pneumocystis jirovecii DNA [Presence] in Specimen by NAA with probe detection

158

3.33

14.21

1.4

1.6

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

265

2.76

14.14

1.3

1.1

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

5.69

14.13

1.2

1.0

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

283

2.69

14.04

1.9

1.5

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

288

4439

0.61

13.88

1.3

17.08

12.80

u/ml

0.40

106

1739

(40768441) Liver Pathology biopsy report

108

3.83

13.85

1.2

1.7

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

2131

23256

0.73

13.68

5.4

5.2

1.82

1.94

mu/l

3.79

1983

21498

(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

+∞

13.55

1.1

0.0

—

(1617658) Protocol used for examination of sentinel lymph nodes

+∞

13.55

1.0

0.0

—

(1616796) Gas panel - Central venous blood

115

537

2.19

13.51

3.6

3.9

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

112

518

2.21

13.47

1.5

1.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

112

518

2.21

13.47

1.5

1.3

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

16.26

13.44

1.1

—

(3012544) pH of Venous blood

405

2765

1.53

13.33

5.3

3.9

7.39

7.38

1.75

249

1593

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

291

1853

1.63

12.91

5.9

3.0

1.22

1.23

mmol/l

1.24

269

1564

(3001964) Herpes simplex virus Ag [Presence] in Specimen

4.86

12.84

2.1

1.3

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

1212

10088

1.33

12.75

4.1

3.9

79.21

88.55

ng/l

0.07

949

7164

(3007853) Bacteria identified in Skin by Aerobe culture

421

2937

1.50

12.48

1.7

1.8

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

100

456

2.23

12.47

1.3

1.5

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

138

715

1.97

12.31

2.7

2.8

102.19

91.98

5.31

133

700

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

10.52

12.23

1.3

1.4

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

131

669

2.00

12.18

2.9

2.5

202.47

182.87

1.53

125

636

(3035933) Granulocytes/Leukocytes in Blood

101

469

2.19

12.06

4.2

3.1

56.46

57.52

0.27

101

469

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

143

756

1.93

12.04

3.0

1.5

48.01

23.94

u/ml

1.90

137

723

(40768793) Breast Pathology biopsy report

165

3.06

11.99

1.3

1.1

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

552

4091

1.42

11.91

1.6

1.9

—

(3017354) Segmented neutrophils/Leukocytes in Blood

187

2.92

11.91

2.5

2.3

66.23

58.57

2.24

150

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

328

4753

0.65

11.78

1.4

1.3

31.99

32.30

iu/ml

0.02

109

1412

(3000963) Hemoglobin [Mass/volume] in Blood

2581

27181

0.70

11.78

41.2

21.6

132.65

136.80

g/l

37.54

2563

26827

(3010813) Leukocytes [#/volume] in Blood

2581

27180

0.70

11.76

40.7

21.5

6.97

6.73

e9/l

4.72

2528

26409

(3024354) Oxygen [Partial pressure] in Venous blood

345

2336

1.54

11.74

5.2

3.3

4.70

4.59

kpa

0.41

336

2256

(3009542) Hematocrit [Volume Fraction] of Blood by calculation

2581

27175

0.70

11.67

41.5

21.9

39.59

41.02

7.59

2558

26803

(3026361) Erythrocytes [#/volume] in Blood

2581

27175

0.70

11.67

40.7

21.4

4.40

4.53

e12/l

32.82

2526

26414

(3035941) MCH [Entitic mass]

2581

27174

0.70

11.65

40.6

21.4

30.51

30.36

4.04

2556

26817

(3024731) MCV [Entitic mean volume] in Red Blood Cells

2581

27172

0.70

11.62

40.6

21.4

91.41

91.04

3.90

2558

26812

(3007461) Platelets [#/volume] in Blood

2580

27163

0.70

11.61

40.7

21.5

239.67

247.18

e9/l

6.20

2530

26515

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

3.75

11.55

5.4

1.1

44.14

102.60

u/ml

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

103

491

2.14

11.53

1.6

1.4

—

(44790047) Parainfluenza type 1 nucleic acid detection

289

2.49

11.47

1.6

1.5

—

(44806118) Parainfluenza type 4 nucleic acid detection

289

2.49

11.47

1.6

1.5

—

(44790049) Parainfluenza type 3 nucleic acid detection

289

2.49

11.47

1.6

1.5

—

(44790048) Parainfluenza type 2 nucleic acid detection

289

2.49

11.47

1.6

1.5

—

(3028026) IgM [Mass/volume] in Serum or Plasma

226

1391

1.67

11.45

2.6

1.5

1.46

1.19

g/l

0.79

211

1286

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

4.84

11.42

2.1

2.4

1.79

2.81

ratio

1.01

(3028679) Herpes simplex virus Ab [Presence] in Serum

124

3.34

11.35

1.1

1.2

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

160

900

1.82

11.13

2.2

1.4

23.18

25.24

iu/l

0.37

132

760

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

4.08

11.12

2.3

2.4

510.00

3405.58

u/ml

—

(40765096) Chromosome analysis panel by Banding

8.57

11.01

1.3

1.0

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

4.11

10.86

1.0

1.1

—

(3035715) Granulocytes [#/volume] in Blood

379

2.25

10.79

3.8

3.4

4.51

4.10

e9/l

0.64

379

(3027945) Reticulocytes/Erythrocytes in Blood

402

2868

1.46

10.57

2.9

2.4

1.80

1.76

0.36

372

2528

(3020951) Lymphocytes/Leukocytes in Cerebral spinal fluid

7.90

10.09

1.9

1.1

55.92

46.25

0.30

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

494

2.04

9.88

1.9

1.5

—

(3052851) Hemolysis interference index of Serum or Plasma

123

662

1.89

9.87

4.1

3.5

2.79

2.02

index

0.74

340

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

5.15

9.83

1.3

1.1

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

247

1616

1.57

9.78

5.9

4.1

24.80

24.19

mmol/l

3.03

241

1595

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

3.74

9.59

1.2

1.1

—

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

118

3.16

9.45

4.4

1.9

4.38

3.76

nmol/l

0.21

112

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

329

2.25

9.45

1.5

1.3

—

(42868678) Cholesterol non HDL [Moles/volume] in Serum or Plasma

106

1933

0.53

9.44

1.7

3.45

3.50

mmol/l

0.19

1364

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

657

5190

1.34

9.36

3.8

4.0

133.14

481.01

ng/l

6.04

522

4138

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

12.36

9.35

1.0

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

410

2.08

8.93

1.3

1.5

121.46

139.93

au/ml

0.50

146

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

127

719

1.80

8.71

10.9

4.2

1.38

1.56

mg/l

1.67

116

649

(40760892) CBC W Ordered Manual Differential panel - Blood

683

5477

1.32

8.68

7.8

4.4

—

(3042631) Mycobacterium sp identified in Specimen

268

2.30

8.42

1.9

3.1

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

259

1770

1.51

8.42

2.2

2.4

10.08

20.64

au/ml

4.22

170

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

+∞

8.33

1.0

0.0

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

169

2616

0.63

8.07

1.9

2.0

3.43

3.53

ratio

0.60

144

2056

(3023520) Reticulocytes [#/volume] in Blood

303

2163

1.44

7.90

3.0

2.2

71.31

68.77

e9/l

0.56

230

1569

(40758292) HTLV I+II Ab panel - Serum

7.76

7.86

1.4

1.1

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

237

1615

1.51

7.82

1.2

1.3

54.35

55.55

au/ml

—

113

(3037692) Legionella sp identified in Specimen by Organism specific culture

3.66

7.73

1.3

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

3.44

7.66

1.2

1.1

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

913

0.40

7.66

1.2

1.50

1.51

g/l

0.08

913

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

167

1058

1.61

7.61

1.9

2.0

34.96

39.65

u/l

2.44

150

927

(3008536) Aspergillus sp Ab [Presence] in Serum

6.16

7.53

1.7

1.3

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

3.81

7.52

2.0

1.2

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

7.11

7.47

1.1

1.3

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

844

0.38

7.43

1.2

1.1

0.56

0.65

ratio

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

290

2.16

7.41

2.0

1.5

0.22

0.35

nmol/l

2.17

239

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

3.44

7.38

1.2

1.1

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

1357

15172

0.81

7.38

2.9

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

3.35

7.37

1.2

1.1

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

5.97

7.36

1.1

1.3

—

(21494434) Karyotype in Bone marrow

121

2.83

7.26

1.1

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

360

2.02

7.24

1.1

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

169

2.51

7.08

2.0

1.4

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

3.77

7.07

1.6

3.4

34.71

45.21

1.18

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

209

1418

1.51

7.06

3.2

3.1

4.26

4.53

pmol/l

3.26

192

1254

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

1030

11810

0.81

7.00

2.1

94.89

95.48

pmol/l

0.16

578

6207

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

137

846

1.65

6.95

1.9

1.7

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

409

1.93

6.87

1.6

1.4

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

3.64

6.74

2.0

1.2

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

3.64

6.74

2.0

1.2

—

(3024869) Neuronal Ab [Presence] in Serum

4.02

6.61

1.0

1.1

—

(40761536) Microorganisms panel - Urine sediment

260

1867

1.43

6.58

4.6

3.8

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

417

1.89

6.51

1.6

1.3

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

3.02

6.49

1.1

1.0

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

1028

11725

0.82

6.48

3.0

3.1

176.95

120.66

ug/l

4.05

957

10937

(3014043) Spermatozoa Nonprogressive/Spermatozoa in Semen

3.59

6.31

3.3

6.7

7.70

7.68

0.01

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

614

7386

0.79

6.29

4.0

3.7

22.84

24.12

1.18

301

3349

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

3.35

6.27

1.2

1.1

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

199

2.28

6.21

2.0

1.2

2.97

2.98

ug/l

0.01

178

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

220

1556

1.45

6.06

3.9

4.3

2.10

1.78

mmol/l

0.67

179

1108

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

2.89

6.04

3.7

3.0

1.24

1.57

ug/l

0.27

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

128

2.59

6.04

1.8

1.4

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

479

5905

0.78

5.97

1.3

1.99

1.65

u/ml

0.18

117

1596

(3019225) pH of Specimen

304

2282

1.37

5.94

4.4

3.8

7.38

7.35

0.88

254

1535

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

1812

19490

0.83

5.89

4.8

4.2

14.80

14.82

pmol/l

0.08

1684

17884

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

4.01

5.89

1.6

—

0.68

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

217

2.18

5.87

1.1

—

(21494755) Public health laboratory ask at order entry panel

149

2209

0.66

5.84

1.4

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

114

2.65

5.72

1.8

1.4

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

5.58

5.67

1.7

1.4

—

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

202

1425

1.45

5.65

3.4

2.9

1.19

1.24

0.30

202

1417

(3051611) Lipemic interference index of Serum or Plasma

223

2.12

5.51

4.7

3.7

14.89

14.01

index

0.15

123

(3004119) Hemoglobin [Mass/volume] in Venous blood

233

1700

1.40

5.42

4.1

3.1

129.35

131.27

g/l

0.64

228

1644

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

138

911

1.54

5.36

2.2

1.8

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

294

2233

1.35

5.34

2.1

2.3

33.26

61.29

u/l

0.68

246

1846

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

119

2.54

5.28

1.9

1.4

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

5.40

5.22

1.1

—

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

189

1340

1.44

5.17

5.0

3.7

48.79

48.36

0.08

189

1314

(3014148) Varicella zoster virus Ab [Titer] in Serum

326

1.89

5.17

1.1

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

121

783

1.57

5.15

2.4

1.7

416.83

290.54

mu/l

1.75

114

714

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

306

1.91

5.11

1.4

1.9

—

1493.33

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

5.20

5.07

1.1

1.0

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

178

2478

0.70

5.02

1.4

1.5

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

740

0.47

5.00

1.3

—

(3028433) Virus identified in Specimen by Culture

2.87

4.92

1.2

1.1

—

(3037756) Immunofixation for Serum or Plasma

428

1.75

4.88

1.8

1.2

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

263

1.95

4.82

1.7

2.0

14263.95

29.30

u/ml

0.49

235

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

109

700

1.58

4.82

3.4

1.5

2.20

1.69

ratio

0.45

402

(3009343) pH of Capillary blood

237

1772

1.37

4.78

4.1

4.4

7.42

7.41

1.55

211

1457

(3011985) Renin [Units/volume] in Plasma

350

1.82

4.76

1.7

1.4

38.99

87.31

mu/l

1.56

316

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

802

9156

0.83

4.70

4.8

4.0

2.91

1.93

ug/l

1.79

714

8300

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

242

1824

1.35

4.64

4.0

4.3

5.19

5.17

kpa

0.14

235

1732

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

172

2.16

4.62

2.1

1.2

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

172

2.16

4.62

2.1

1.2

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

172

2.16

4.62

2.1

1.2

—

(3048689) Calprotectin [Mass/mass] in Stool

248

3229

0.75

4.60

2.6

184.58

145.10

ug/g

0.57

207

2587

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

2.69

4.57

2.0

1.2

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

2.69

4.57

2.0

1.2

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

2.69

4.57

2.0

1.2

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

2.69

4.57

2.0

1.2

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

4.53

4.55

1.1

1.2

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

123

2.37

4.48

1.1

1.4

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

4.39

4.43

1.1

1.0

—

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

1045

11607

0.85

4.37

2.5

75.82

77.40

nmol/l

1.02

958

10414

(4094501) Cardiovascular stress test using bicycle ergometer

766

0.52

4.32

1.1

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

225

1.97

4.30

1.5

1.4

1.29

1.28

promille

0.01

173

(3020564) Creatinine [Moles/volume] in Serum or Plasma

2571

26537

0.82

4.22

34.3

18.4

75.32

79.09

umol/l

5.59

2545

26159

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

4.35

4.12

1.1

2.2

—

(3020630) Protein [Mass/volume] in Serum or Plasma

261

2027

1.31

4.11

3.8

1.6

65.12

66.71

g/l

2.39

234

1827

(3000012) Reticulocyte production index

317

1.78

4.03

2.9

1.7

1.01

0.88

0.83

211

(3003888) Timothy IgE Ab [Units/volume] in Serum

479

0.41

4.02

1.3

1.1

3.91

4.49

u/ml

0.06

266

(3004588) Protein electrophoresis panel - Serum or Plasma

223

1699

1.34

4.01

3.1

1.5

—

(4010399) Spirometry for bronchospasm with prolonged evaluation after bronchodilator

142

1974

0.71

4.01

1.4

1.5

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

6.44

3.98

1.0

1.1

—

(3005322) IgE [Units/volume] in Serum or Plasma

121

1728

0.69

3.98

1.4

1.3

269.53

233.26

u/ml

0.20

111

1607

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

4.07

3.89

1.0

1.2

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

2.89

3.89

1.4

2.3

21.14

19.22

umol/l

0.26

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

904

0.58

3.88

1.8

1.9

4.26

4.68

mg/l

0.15

655

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

337

1.73

3.84

1.4

314.31

324.93

pmol/l

0.10

288

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

6.01

3.81

1.7

4.0

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

242

3075

0.77

3.76

1.6

1.8

1.78

1.49

2.80

203

2721

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

12.02

3.76

7.2

1.0

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

465

0.43

3.76

1.3

1.1

1.58

1.34

u/ml

—

216

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

740

0.55

3.69

1.4

1.6

1068.64

1010.95

mu/l

0.15

617

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

2543

26214

0.83

3.67

20.1

10.4

30.45

26.47

u/l

12.73

2503

25318

(3000494) Fungus identified in Specimen by Culture

367

3021

1.24

3.63

1.5

—

(3013707) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method

1773

18768

0.87

3.55

4.4

12.59

11.54

mm/h

2.04

1666

17559

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

113

786

1.45

3.52

3.7

1.5

30.74

34.24

mg/l

0.30

654

(3014133) Dog dander IgE Ab [Units/volume] in Serum

395

0.40

3.50

1.2

1.1

9.53

3.93

u/ml

—

209

(3046861) Legionella sp Ag [Presence] in Urine

10.01

3.49

1.0

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

113

788

1.45

3.48

3.7

1.5

34.86

47.04

mg/l

2.53

659

(3016244) Insulin [Units/volume] in Serum or Plasma

152

2.05

3.45

3.9

3.5

17.10

26.91

mu/l

0.83

145

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

456

5345

0.83

3.43

3.0

2.8

0.74

0.71

ug/l

0.33

316

3348

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

3.76

3.38

1.1

1.0

—

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

2.58

3.38

1.2

1.1

80.56

106.17

1.84

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

127

2.14

3.35

1.1

1222.67

1615.98

miu/ml

1.05

127

(1761482) Bacteria [#/volume] in Urine by Culture

573

1.51

3.33

4.7

4.1

—

(3000492) Spirometry study

198

2538

0.76

3.31

1.5

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

681

1.47

3.29

1.3

1.2

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

546

0.51

3.28

1.2

1.1

5.70

2.23

u/ml

0.47

307

(40768806) Pleura Pathology biopsy report

176

1.94

3.28

1.7

1.4

—

(46236952) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)/1.73 sq M

246

1962

1.28

3.21

3.4

2.3

65.13

66.81

ml/min/173m2

0.22

786

(4062490) Immunoglobulin typing, IgG

250

1.77

3.20

1.4

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

5.34

3.19

1.1

1.4

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

129

1749

0.73

3.18

1.2

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

1178

0.67

3.15

1.5

1.7

0.39

0.32

mg/l

0.44

571

(3023430) Cat dander IgE Ab [Units/volume] in Serum

362

0.41

3.14

1.2

1.1

14.01

4.63

u/ml

—

172

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

461

1.55

3.11

1.4

256.49

255.17

u/ml

0.01

275

(3020876) Protein [Mass/time] in 24 hour Urine

260

1.74

3.10

2.0

2.1

1.25

1.71

g/24h

0.55

144

(3024139) IgG subclass 3 [Mass/volume] in Serum

253

1.75

3.08

1.4

0.34

0.38

g/l

0.42

190

(3027135) IgG subclass 1 [Mass/volume] in Serum

253

1.75

3.08

1.4

6.00

6.89

g/l

1.13

191

(3028192) IgG subclass 2 [Mass/volume] in Serum

253

1.75

3.08

1.4

2.51

2.99

g/l

1.07

189

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

3.68

3.08

1.0

1.2

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

4.01

3.08

2.2

2.3

3.90

4.80

ug/l

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

7.51

3.05

7.5

6.0

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

5.01

3.05

1.0

1.1

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

2.51

3.04

1.2

1.1

83.56

91.62

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

2.47

2.95

1.2

1.0

87.89

89.35

—

(3003338) MCHC [Entitic Mass/volume] in Red Blood Cells

2023

21115

0.88

2.93

35.1

18.3

333.63

332.80

g/l

3.54

2005

20991

(3024928) Oxygen saturation in Venous blood

699

1.43

2.91

4.2

3.1

62.57

62.52

0.01

674

(3001019) Free T4 and TSH panel - Serum or Plasma

1082

0.68

2.84

1.4

1.7

—

(3000475) Leukocytes [#/volume] in Synovial fluid

694

0.60

2.81

1.5

8932.53

12171.78

e6/l

0.57

491

(4281824) Cell count and differential, peritoneal fluid

117

2.06

2.76

1.2

1.1

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

2.17

2.76

2.0

1.6

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

2.17

2.76

2.0

1.6

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

104

749

1.40

2.76

1.3

—

(3021960) Folate [Moles/volume] in Serum or Plasma

677

7546

0.87

2.70

1.7

19.41

20.16

nmol/l

0.70

601

6350

(3020393) Adenovirus Ag [Presence] in Stool

3.15

2.64

1.4

1.8

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

441

0.52

2.62

1.2

1.1

3.40

1.57

u/ml

0.32

229

(40764999) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M

2296

23709

0.88

2.59

26.8

13.6

85.31

80.13

ml/min/173m2

27.28

2142

21714

(3019150) Specific gravity of Urine by Refractometry

549

6195

0.86

2.59

4.2

4.0

1.02

1.27

kg/l

0.50

383

4053

(3009385) Beta-2-Microglobulin [Mass/volume] in Cerebral spinal fluid

7.15

2.55

1.2

1.1

1.90

1.33

mg/l

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

131

994

1.33

2.53

5.0

4.8

25.43

24.63

mmol/l

1.97

125

908

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

197

2437

0.80

2.52

1.8

2.1

—

(21494890) Protein electrophoresis panel - 24 hour Urine

216

1.72

2.51

2.1

1.2

—

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

357

1.55

2.48

1.4

0.61

5.58

nmol/l

0.50

344

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

3.82

2.46

1.1

1.0

—

(4146454) Self-monitoring of blood glucose

310

0.45

2.43

2.1

2.7

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

5.01

2.40

1.0

—

(3035947) Staphylolysin Ab [Units/volume] in Serum

2.07

2.37

1.1

—

4.30

iu/ml

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

4.12

2.36

1.1

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

4.12

2.36

2.0

1.8

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

216

0.41

2.30

1.3

1.4

112.34

209.83

pmol/l

—

216

(3040151) Glucose [Moles/volume] in Capillary blood

324

1.55

2.29

14.0

6.4

6.93

7.36

mmol/l

0.46

273

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

117

888

1.33

2.29

2.3

1.4

9.68

10.22

g/l

0.63

102

774

(3024980) IgG subclass 4 [Mass/volume] in Serum

414

1.48

2.27

1.4

1.7

0.51

0.90

g/l

3.75

333

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

412

3595

1.17

2.24

2.6

2.8

23.53

22.92

0.34

385

3328

(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay

0.00

2.23

0.0

1.1

—

64.54

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

180

2216

0.80

2.23

1.7

2.1

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

194

1.71

2.22

1.3

1.2

110.33

107.13

pmol/l

0.12

194

(3022475) Manganese [Moles/volume] in Blood

5.56

2.21

1.4

1.0

0.14

umol/l

—

(3039443) Prostate specific Ag panel - Serum or Plasma

527

0.60

2.18

1.5

1.6

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

262

3098

0.83

2.18

4.1

5.1

32.00

32.43

0.28

197

2040

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

3.34

2.18

1.1

1.0

—

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

1253

0.74

2.17

1.1

—

1.44

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

144

1.81

2.14

2.2

1.8

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

264

0.45

2.09

1.4

1.5

48.75

59.11

ug/l

0.65

264

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

3.20

2.09

1.9

1.1

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

356

0.53

2.08

1.3

1.6

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

365

1.49

2.07

1.3

1.2

—

(3036603) Volume of Urine

146

1.79

2.06

1.6

1.5

1858.27

1922.76

0.20

140

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

132

1.82

2.03

2.4

3.0

101.79

98.27

0.15

126

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

128

1003

1.29

2.02

2.4

1.4

7.46

7.48

g/l

0.05

115

893

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

128

1003

1.29

2.02

2.4

1.4

4.21

4.24

g/l

0.14

115

895

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

303

1.53

2.00

1.4

1.3

0.20

0.19

nmol/l

0.20

251

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

2.64

2.00

1.2

1.0

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

310

0.51

1.96

2.5

1.7

—

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

112

1.88

1.96

1.3

1.5

—

1199236.27

iu/ml

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

701

1.34

1.95

2.5

1.4

0.00

g/l

-0.00

623

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

667

1.34

1.94

1.3

1.2

—

(3004269) Kappa light chains [Mass/time] in 24 hour Urine

3.75

1.93

2.2

1.6

—

(3044941) Cell count panel - Synovial fluid

497

0.62

1.93

1.6

1.4

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

127

1002

1.28

1.92

2.4

1.4

3.47

3.76

g/l

2.03

114

893

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

140

1119

1.26

1.91

1.8

1.7

1.67

1.53

g/l

0.80

123

964

(3014271) Vancomycin [Susceptibility]

128

1.80

1.89

3.1

2.9

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

731

1.32

1.89

2.5

1.4

0.05

0.00

g/l

0.58

667

(3050794) Legionella sp Ab [Presence] in Serum

3.53

1.83

1.2

1.0

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

119

938

1.28

1.83

2.3

1.4

2.89

2.91

g/l

0.08

105

829

(3022313) Gas panel - Capillary blood

155

1261

1.24

1.82

4.5

4.7

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

4.17

1.82

1.0

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

4.17

1.82

1.0

—

(3016184) Myelin associated glycoprotein Ab [Units/volume] in Serum

4.17

1.82

1.8

1.2

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

440

0.61

1.82

1.3

1.5

79.29

60.19

ug/l

0.68

368

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

749

8099

0.90

1.74

3.3

1012.30

1466.59

ng/l

5.59

667

6957

(3012441) Differential panel - Pleural fluid

201

1.60

1.74

1.5

1.4

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

109

856

1.28

1.74

2.8

1.4

1.13

0.39

g/l

1.49

736

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

663

1.32

1.73

2.5

1.4

0.00

g/l

-0.00

622

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

0.00

1.68

0.0

1.1

—

44.27

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

308

1.47

1.68

1.4

1.3

—

nmol/l

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

1739

16716

1.09

1.65

3.9

3.2

64.51

45.97

u/l

5.96

1658

15642

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

393

1.41

1.64

1.1

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

385

1.41

1.63

1.1

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

972

0.76

1.61

1.7

1.6

17.47

17.57

u/ml

0.00

208

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

3.57

1.61

1.0

1.1

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

3.00

1.58

1.3

1.1

—

(3035320) C reactive protein [Mass/volume] in Body fluid

199

1.56

2.1

2.7

34.30

30.69

mg/l

0.21

141

(3004789) Transferrin [Mass/volume] in Serum or Plasma

437

3937

1.13

1.54

2.5

2.7

2.28

2.31

g/l

0.56

412

3622

(3047189) Immunofixation for 24 hour Urine

1.93

1.54

1.3

1.1

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

115

1.74

1.52

1.3

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

2521

24704

1.11

1.46

28.0

14.3

21.98

23.67

mg/l

2.22

2330

19991

(3052592) Norovirus Ag [Presence] in Stool

2.37

1.45

1.1

1.4

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

2.50

1.45

1.4

1.0

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

2.50

1.45

1.4

1.0

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

2.50

1.45

1.4

1.0

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

1.92

1.43

1.4

1.3

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

1.92

1.43

1.4

1.3

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

227

0.53

1.43

1.1

1.3

3.18

2.24

u/ml

—

136

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

1.97

1.43

3.1

2.8

0.63

0.61

mmol/l

0.51

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

275

3118

0.87

1.42

1.4

1.5

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

600

5529

1.11

1.42

1.9

1.8

1.75

1.22

mg/l

1.99

493

4231

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

254

1.46

1.40

1.4

1.2

—

(3033799) Differential panel - Peritoneal fluid

2.18

1.39

1.6

1.8

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

642

1.28

1.39

2.1

2.2

131.12

131.68

g/l

0.07

519

(3008402) Methanol [Moles/volume] in Serum or Plasma

2.42

1.39

1.1

—

mmol/l

—

(3015616) Isopropanol [Moles/volume] in Serum or Plasma

2.42

1.39

1.1

1.2

—

mmol/l

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

511

5571

0.90

1.39

1.6

1.7

47887810.68

32708486.87

pmol/l

0.18

426

4638

(3025468) Yersinia sp identified in Specimen by Organism specific culture

255

1.46

1.38

1.4

1.2

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

348

0.63

1.37

1.4

1.5

—

(3007566) Smooth muscle Ab [Titer] in Serum

698

1.27

1.35

1.1

1.2

56.15

109.70

titre

2.61

(3005988) Vibrio sp identified in Specimen by Organism specific culture

256

1.45

1.35

1.4

1.2

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

106

1298

0.81

1.35

1.0

1.1

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

406

0.66

1.34

1.4

1.5

1.31

1.22

ratio

0.24

254

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

406

0.66

1.34

1.4

1.5

0.93

0.97

ratio

0.19

254

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

406

0.66

1.34

1.4

1.51

1.12

ratio

0.54

254

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

1.87

1.34

1.0

—

(4198724) Urine methamphetamine measurement

105

1.72

1.33

1.3

2.2

—

(40768797) Stomach Pathology biopsy report

304

3405

0.88

1.32

1.2

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

208

1.49

1.32

1.5

1.4

26380.63

65327.96

e6/l

0.56

118

(3003191) Choriogonadotropin [Presence] in Serum or Plasma

419

1.34

1.32

1.5

1.8

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

149

0.47

1.31

3.1

1.8

173.71

117.76

ng/l

—

149

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

275

1.42

1.30

1.4

1.2

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

402

0.67

1.29

1.4

—

(3016750) Collection duration of Urine

145

1.59

1.28

2.1

524.88

499.90

min

1.03

108

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

1.89

1.28

1.2

1.1

—

(3032057) Clostridioides difficile [Presence] in Stool

2.09

1.27

4.0

1.9

—

(36660697) Celiac disease serology panel - Serum

181

2096

0.85

1.27

1.1

1.2

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

249

2197

1.14

1.25

2.6

2.4

11.96

14.70

nmol/l

6.23

223

2002

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

386

4245

0.90

1.24

1.4

1.5

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

1085

0.81

1.22

1.6

2.1

—

(4024509) Urine culture

101

1227

0.82

1.22

1.8

1.9

—

(3010838) Calcium [Moles/time] in 24 hour Urine

434

1.32

1.22

1.7

2.1

4.75

4.96

mmol/24h

0.16

376

(40757373) Influenza virus identified in Isolate

2.04

1.22

1.4

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

337

0.65

1.21

1.4

1.5

—

(3000093) Morphology [Interpretation] in Blood Narrative

222

1.45

1.18

1.0

1.1

—

(3022948) Iron [Moles/volume] in Serum or Plasma

463

4253

1.10

1.18

2.5

2.7

13.31

13.20

umol/l

0.11

434

3937

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

206

1.46

1.17

2.7

2.3

1.33

1.68

u/field

0.38

126

(43055514) Macroprolactin [Presence] in Serum or Plasma

1.93

1.17

1.5

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

2.00

1.16

1.7

1.1

—

(3005033) Fetal Nuchal fold Thickness US

332

0.66

1.14

1.4

1.31

1.29

0.06

235

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

210

0.57

1.14

1.0

1.3

10.25

8.82

mmol/l

0.50

200

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

197

0.56

1.14

1.2

—

(3000330) Specific gravity of Urine by Test strip

151

1294

1.18

1.13

4.1

3.2

1.02

ratio

2.23

140

1185

(3026470) Cobalt [Mass/volume] in Blood

156

0.51

1.13

2.0

2.3

2.19

3.03

ug/l

—

148

(3017732) Neutrophils [#/volume] in Blood

342

3103

1.11

3.8

2.9

4.60

4.67

e9/l

0.05

304

2671

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

575

1.26

1.10

1.0

1.3

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

137

0.51

1.09

1.0

1.3

—

(3024263) Appearance of Synovial fluid

139

0.50

1.09

1.4

1.7

—

(3012565) Volume of 24 hour Urine

104

1.64

1.09

2.0

2.1

2126.47

2069.17

0.11

(3026480) Teichoate Ab [Titer] in Serum

2.38

1.09

1.2

1.0

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

109

1297

0.83

1.08

1.6

2.2

—

(3003129) Base excess in Capillary blood by calculation

327

0.67

1.08

1.7

2.2

0.11

0.53

mmol/l

0.30

315

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

776

1.22

1.07

1.1

1.4

—

(3035880) pH of Pleural fluid

1.65

1.06

1.4

1.3

7.35

7.44

0.82

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

270

1.37

1.06

1.4

1.2

—

(3044007) Cell count panel - Peritoneal fluid

1.93

1.06

1.5

2.3

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

113

1.60

1.05

1.3

—

(3018133) Calcium [Moles/volume] in Urine

1.84

1.02

1.5

2.0

3.04

2.49

mmol/l

0.30

(3004775) Volume in Urine collected for unspecified duration

205

1.42

1.00

2.1

2.3

639.16

623.93

0.09

133

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

172

1.46

0.99

1.0

1.1

3.28

12.82

nmol/l

—

(3023420) DNA double strand Ab [Units/volume] in Serum

1090

0.83

0.99

1.6

1.8

5.66

6.31

iu/ml

0.09

252

(3050129) First trimester maternal screen panel - Serum or Plasma

481

0.75

0.98

1.2

1.4

—

(3009015) Lactate [Moles/volume] in Synovial fluid

0.00

0.97

0.0

1.2

—

5.73

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

0.00

0.97

0.0

1.2

—

6.09

—

(3006571) Granulocytes/Leukocytes in Synovial fluid

306

0.68

0.95

1.5

55.45

62.75

0.37

195

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

1.62

0.93

1.1

1.2

—

(3023199) Leukocytes [#/volume] in Pleural fluid

243

1.36

0.92

1.5

1.4

1245.30

1800.04

e6/l

0.73

170

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

653

0.79

0.90

2.6

2.2

274.65

111.01

ug/min

0.51

394

(1002224) Polysomnography panel

105

1227

0.85

0.89

1.1

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

760

0.81

0.88

1.9

2.0

202.71

211.20

pmol/l

0.29

720

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

119

1.52

0.88

1.9

1.8

1.31

3.49

u/field

0.83

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

119

1.52

0.88

2.1

2.3

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

395

1.27

0.87

1.1

1.3

5.25

5.71

u/ml

0.09

190

(3044927) Protein electrophoresis panel - Urine

288

0.69

0.87

1.2

1.1

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

2.00

0.87

1.0

1.1

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

824

7857

1.07

0.85

2.9

2.5

57.58

60.06

u/l

0.48

773

7252

(3024522) Salmonella sp identified in Specimen by Organism specific culture

273

1.32

0.85

1.4

1.2

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

623

1.21

0.85

2.3

2.1

1489.36

4517.83

u/l

1.10

265

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

638

6736

0.93

0.84

2.2

2.4

2.92

2.74

mg/l

1.10

563

5809

(3025018) Bordetella pertussis Ab [Titer] in Serum

165

0.60

0.81

1.1

1.2

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

676

0.81

1.4

1.5

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

382

1.26

0.81

1.1

—

(3008898) HLA-B27 [Presence]

849

0.83

0.80

1.0

1.1

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

0.00

0.79

0.0

1.0

—

7.32

—

(36306063) Golimumab Ab [Mass/volume] in Serum or Plasma by Immunoassay

0.00

0.79

0.0

2.0

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

262

2397

1.10

0.78

2.2

2.4

5.28

8.07

ug/l

3.04

226

2121

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

1.62

0.78

1.1

1.2

—

(3003329) Lymphocytes/Leukocytes in Synovial fluid

234

0.68

0.77

1.7

1.5

35.10

28.69

—

150

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

1.77

0.76

9.0

11.0

5.05

5.80

mmol/l

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

209

1.34

0.75

1.1

—

(3037522) Nuclear Ab [Titer] in Serum

334

3596

0.92

0.75

1.3

531.23

534.50

titre

0.01

775

(3019832) Treponema pallidum Ab [Presence] in Serum

223

2030

1.11

0.74

1.4

1.8

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

635

0.82

0.74

1.5

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

405

1.24

0.74

1.2

1.1

—

0.93

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

160

0.62

0.73

1.0

1.1

—

(3022145) Colonoscopy Study observation

235

2567

0.91

0.73

1.3

1.4

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

272

1.29

0.72

1.2

1.1

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

230

0.69

0.72

1.1

1.3

—

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

110

0.54

0.72

1.0

1.1

153.30

194.73

iu/ml

—

110

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

426

1.22

0.70

1.5

1.6

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

1.92

0.70

1.2

1.1

—

(3045788) Cell count panel - Pleural fluid

203

1.33

0.70

1.6

1.4

—

(3023511) Choriogonadotropin [Units/volume] in Urine

309

0.74

0.70

1.5

1.3

—

(4195642) Thrombophilia screening test

363

1.24

0.70

1.1

1.2

—

(3049717) Cytology report of Urine Cyto stain

740

1.17

0.69

3.5

1.8

—

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

180

0.67

28.3

19.2

1232.00

1378.78

nmol/l

0.30

174

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

581

0.82

0.65

1.2

7.51

50.20

u/ml

—

(3029634) Reagin Ab [Titer] in Serum by VDRL

358

1.23

0.65

1.7

2.2

—

6.67

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

236

0.72

0.64

1.5

—

(3002523) Influenza virus A Ag [Presence] in Specimen

437

0.80

0.63

1.2

1.1

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

131

0.61

0.63

3.0

1.7

—

(3003740) Influenza virus B Ag [Presence] in Specimen

436

0.80

0.63

1.2

1.1

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

991

10235

0.95

0.62

4.3

3.7

0.04

0.08

estimate

0.41

283

2186

(3045414) Leukocytes [Presence] in Urine

226

2449

0.92

0.62

2.0

0.00

0.01

estimate

0.78

502

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

165

1.34

0.60

1.2

1.5

—

(3025549) Creatine [Moles/time] in 24 hour Urine

0.00

0.60

0.0

1.6

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

0.00

0.60

0.0

1.0

—

0.31

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

779

0.86

0.60

1.2

15.52

41.03

u/ml

—

(3041082) Glomerular basement membrane Ab [Titer] in Serum by Immunofluorescence

0.00

0.59

0.0

1.0

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

220

0.73

0.59

2.4

1.7

12.33

25.08

u/ml

—

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

106

1.42

0.57

1.6

1.4

4.15

4.80

umol/l

0.26

(3001893) Eosinophils/Leukocytes in Pleural fluid

1.48

0.57

1.7

1.4

4.75

3.23

—

(3044242) Glucose [Moles/volume] in Arterial blood

161

0.68

0.57

1.4

1.6

7.43

8.47

mmol/l

0.94

161

(3015171) Extractable nuclear Ab [Units/volume] in Serum

1008

0.88

0.56

1.1

1.2

0.64

1.12

u/ml

—

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

172

0.70

0.56

13.8

15.0

624.58

795.69

nmol/l

0.72

166

(40761539) Cells [Type] in Urine sediment by Light microscopy

1.46

0.56

1.3

1.1

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

124

1.37

0.55

1.9

2.7

280.18

168.47

umol/l

0.30

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

1.62

0.55

2.0

2.3

—

(3029396) Erythrocyte agglutination [Presence] in Blood

1.62

0.55

1.5

3.7

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

1.62

0.55

2.0

2.3

—

(3027944) Amphetamines [Presence] in Urine

942

0.88

0.55

2.5

2.1

—

(3011288) Drugs identified in Urine by Screen method Nominal

633

0.85

0.54

2.2

3.0

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

1.46

0.54

3.1

1.2

22.57

1424.13

pmol/l

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

187

1.29

0.52

1.1

—

(3005532) Lymphocytes/Leukocytes in Pleural fluid

1.52

0.52

1.6

1.4

48.12

57.88

—

(3029937) Albumin [Presence] in Urine by Test strip

773

7467

1.05

0.51

4.2

4.0

0.00

estimate

1.08

309

2473

(3000764) Benzodiazepines [Presence] in Urine

947

0.88

0.51

2.4

2.1

—

(40759850) Jo-1 extractable nuclear Ab [Presence] in Serum by Immunoblot

225

0.75

0.51

1.1

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

734

0.87

0.50

1.2

1.3

27.46

5.69

u/ml

—

105

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

965

0.89

0.49

1.8

2.0

40.19

40.24

nmol/l

0.01

933

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

732

0.87

0.49

1.2

2.39

2.69

u/ml

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

345

0.81

0.49

1.1

1.2

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

671

1.14

0.48

1.2

1.1

—

3.83

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

172

1.28

0.48

1.1

—

(3022621) pH of Urine by Test strip

191

2055

0.92

0.48

2.9

2.6

6.22

6.09

1.21

145

1405

(3002385) Erythrocyte [DistWidth] in Red Blood Cells

2088

20604

1.04

0.48

35.0

17.2

13.97

13.54

32.67

2076

20274

(40760543) Extractable nuclear Ab [Presence] in Serum by Immunoblot

143

0.70

0.47

1.1

—

(40768443) Skin Pathology biopsy report

962

0.89

0.47

1.2

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

148

1606

0.92

0.46

1.2

173.47

139.47

u/ml

0.32

623

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

118

0.68

0.45

4.4

4.6

—

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

118

0.68

0.45

1.4

2.5

162.88

158.75

nmol/l

—

106

(44806420) Estimation of glomerular filtration rate

265

0.79

0.45

2.9

2.5

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

1.43

0.45

1.0

1.1

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

578

0.86

0.45

1.5

2.0

0.89

0.83

nmol/l

0.20

488

(3014051) Protein [Presence] in Urine by Test strip

697

7194

0.96

0.43

3.5

2.9

0.19

0.05

0.43

188

(3028300) Cannabinoids [Presence] in Urine

954

0.90

0.42

2.5

2.1

—

(3009261) Glucose [Presence] in Urine by Test strip

1391

13646

1.03

0.42

4.2

3.8

0.01

estimate

0.15

336

2543

(3002619) Bacteria identified in Specimen by Culture

1.43

0.42

1.1

1.2

—

(3000034) Microalbumin [Mass/volume] in Urine

240

0.79

0.42

2.7

2.9

6.27

40.29

mg/l

2.72

184

(4211845) Urine protein measurement

122

1.31

0.42

2.9

3.3

—

(3004616) Nuclear Ab [Presence] in Serum

327

0.82

0.42

1.3

1.2

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

217

0.78

0.41

1.1

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

261

0.80

0.41

1.1

1.3

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

0.00

0.41

0.0

1.2

—

(3027008) Opiates [Presence] in Urine

951

0.90

0.41

2.4

2.1

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

0.00

0.40

0.0

1.3

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

0.00

0.40

0.0

1.0

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

1.36

0.40

1.3

1.1

—

(3026389) Candida sp identified in Specimen by Organism specific culture

315

1.18

0.40

1.7

1.3

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

399

1.15

0.39

1.2

4.88

3.68

u/ml

0.17

145

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

227

2140

1.07

0.39

2.4

3.4

174.39

219.55

ng/l

1.16

205

1956

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

103

0.68

0.39

1.9

4.3

6.38

8.21

mg/l

—

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

103

0.68

0.39

2.4

2.9

25.34

94.35

ug/l

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

215

0.79

0.39

1.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

215

0.79

0.39

1.1

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

115

1.31

0.38

1.0

8.4

68.50

66.52

mg/l

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

118

1280

0.92

0.38

2.4

—

(3035350) Ketones [Presence] in Urine by Test strip

1384

13597

1.03

0.38

4.1

3.8

11.24

4.96

estimate

0.46

354

2752

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

203

0.79

0.38

1.1

1.2

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

344

0.84

0.37

1.0

1.1

—

2.77

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

289

0.83

0.36

1.0

1.1

—

(3045424) Erythrocytes [Presence] in Urine

112

1213

0.92

0.36

1.9

2.0

0.03

0.65

estimate

0.48

389

(3004716) Salmonella sp identified in Stool by Organism specific culture

105

1138

0.92

0.35

1.3

—

(3016879) Cocaine [Presence] in Urine

878

0.91

0.35

2.5

2.2

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

742

0.90

0.34

2.8

2.2

—

(3042733) HLA Ab [Presence] in Serum

0.68

0.33

5.2

4.4

—

(3025941) Bacteria identified in Stool by Culture

138

1291

1.07

0.32

1.3

1.2

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

1.35

0.32

7.2

7.5

6.91

5.15

kpa

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

653

0.90

0.31

1.1

2.95

7.53

eliau/ml

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

208

0.82

0.31

1.1

1.2

—

(3018333) Ribosomal P Ab [Presence] in Serum

197

0.81

0.31

1.1

—

(3033099) Centromere Ab [Titer] in Serum

1.30

0.30

1.0

1.1

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

129

1.24

0.30

1.1

1.2

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood by calculation

1.27

0.30

6.3

8.1

10.81

10.22

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

713

0.91

0.29

1.4

276.59

296.02

ug/g

0.38

425

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

249

0.84

0.29

1.1

1.2

—

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

747

1.09

0.28

1.1

1.5

—

15.02

—

(3023419) Bacteria identified in Sputum by Culture

337

1.13

0.27

1.9

2.8

—

(3003327) Ova and parasites identified in Stool by Light microscopy

852

0.93

0.26

1.9

1.7

—

(3036071) Salmonella sp Ab [Titer] in Serum

0.69

0.26

1.0

1.1

—

(3017704) Immunofixation for Urine

123

1.22

0.25

1.3

1.2

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

1.27

0.24

1.1

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

203

2117

0.96

0.24

2.6

2.4

0.46

0.42

e6/l

0.09

195

2017

(3025130) Human papilloma virus identified in Specimen

318

0.88

0.24

1.8

—

(3007164) IgA [Mass/volume] in Serum or Plasma

487

4993

0.97

0.24

2.0

1.4

2.20

2.49

g/l

1.77

319

2976

(3032773) Endomysium IgG Ab [Titer] in Serum

243

0.86

0.23

1.0

1.1

—

(3028707) Methadone [Presence] in Urine by Screen method

399

1.10

0.23

3.6

2.9

—

(3019420) Tryptase [Mass/volume] in Serum or Plasma

125

1.20

0.22

1.4

1.6

7.25

8.83

ug/l

0.27

107

(3020911) Cortisol [Moles/time] in 24 hour Urine

1.27

0.22

1.2

1.5

235.70

70.67

nmol/24h

—

(3026493) Urate [Moles/volume] in Serum or Plasma

661

6737

0.98

0.22

3.2

2.4

318.92

351.07

umol/l

12.80

592

5869

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

401

1.10

0.21

1.2

23.14

20.11

u/l

0.24

344

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

0.00

0.21

0.0

1.0

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

0.00

0.21

0.0

4.0

—

(3007463) Buprenorphine [Presence] in Urine

0.00

0.21

0.0

4.7

—

(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose

0.00

0.21

0.0

1.2

—

7.93

—

(3029856) Leukocytes [#/volume] in Peritoneal dialysis fluid

0.00

0.21

0.0

9.5

—

223.20

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

0.00

0.21

0.0

1.5

—

(3022689) Creatine [Moles/volume] in Urine

1.24

0.20

1.5

1.4

6.53

9.09

mmol/l

1.58

(4268621) Lupus anticoagulant assay

287

1.12

0.20

2.2

2.3

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

687

0.93

0.20

1.5

2.0

3.13

12.35

iu/l

0.55

274

(3025059) Transferrin.carbohydrate deficient [Mass/volume] in Serum or Plasma

0.00

0.20

0.0

1.1

—

38.15

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

183

1.15

0.20

1.2

1.6

80.10

85.81

umol/l

0.32

183

(3021601) Nitrite [Presence] in Urine by Test strip

1357

13426

1.02

0.19

4.1

3.8

0.01

0.00

estimate

0.73

338

2679

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

694

0.94

0.18

1.2

1.3

147.00

218.20

miu/ml

0.64

313

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

261

1.11

0.18

2.6

4.1

—

(3041806) Other cells [#/volume] in Blood by Manual count

1.21

0.18

1.9

1.6

0.44

0.47

e9/l

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

541

1.07

0.18

3.3

3.7

32.49

28.00

mg/l

0.24

387

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

1.19

0.18

1.1

1.2

264.86

259.90

pmol/l

—

(3043410) Blood group antigens tested for on Red Blood Cells

1.13

0.17

2.0

1.3

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

643

6325

1.02

0.17

3.7

0.33

0.11

—

(3024932) HLA-DR beta [Type]

0.72

0.17

1.2

1.0

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

167

1.14

0.16

1.3

1.2

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

0.71

0.16

1.0

0.13

1.81

u/ml

—

(3041096) Erythrocytes [Presence] in Urine by Automated

722

7121

1.02

0.15

4.2

3.2

0.04

0.16

estimate

0.46

273

2103

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

429

1.07

0.15

1.1

1.00

1560.29

iu/ml

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

1.11

0.15

2.7

2.8

4.81

5.00

kpa

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

1.11

0.15

2.7

2.8

9.48

9.98

kpa

—

(42529406) Shigella sp [Presence] in Stool by Culture

697

0.95

0.15

1.3

1.1

—

(44813793) Dust mix specific IgE antibody measurement

171

0.88

0.14

1.0

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

0.78

0.14

1.1

1.5

—

(3006462) Nitrate [Presence] in Urine

112

1.16

0.14

3.3

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

100

0.80

0.13

1.1

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

152

1.12

0.12

1.0

—

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

230

0.91

0.11

1.3

1.1

—

85.10

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

690

0.96

0.11

1.3

1.1

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

199

1946

1.02

0.10

3.9

4.1

108.84

90.11

ng/l

1.30

173

1662

(3019550) Sodium [Moles/volume] in Serum or Plasma

2551

25439

1.01

0.10

31.5

17.4

139.14

139.78

mmol/l

25.07

2523

24890

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

687

0.96

0.10

1.3

1.1

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

1.11

0.09

1.2

2.2

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

314

3092

1.02

0.09

10.3

6.6

—

(3002079) Sodium [Moles/time] in 24 hour Urine

116

1.12

0.09

1.1

1.3

200.38

174.85

mmol/24h

0.53

116

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

116

1.12

0.09

1.4

1.8

1.17

5.97

nmol/l

1.68

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

216

0.93

0.08

1.1

1.3

—

330.00

—

(4015189) Microbial culture of sputum

1.08

0.08

1.3

2.7

—

(3004451) EKG impression Narrative

156

1.09

0.08

1.1

1.3

—

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

1.04

0.08

1.3

1.2

—

13.00

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

166

1.08

0.07

1.3

1.2

—

(3024471) HLA-A [Type]

0.86

0.07

1.0

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

100

979

1.02

0.05

1.2

1.3

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

841

1.02

0.05

1.6

1.5

0.00

4.24

iu/ml

0.52

150

(3038177) Helicobacter pylori Ab [Presence] in Serum

384

0.96

0.05

1.2

—

(3019309) Folate [Moles/volume] in Red Blood Cells

459

4557

1.01

0.05

1.8

1122.52

1159.11

nmol/l

0.42

369

3467

(4034850) Laboratory test

864

1.02

0.04

12.6

9.6

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

719

1.02

0.02

1.4

1.3

—

(3015736) pH of Urine

1082

10831

1.00

0.01

3.6

3.4

6.36

6.24

2.72

596

6045

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

146

0.96

0.00

1.3

1.1

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

2551

25498

1.00

0.00

31.2

17.5

3.96

3.99

mmol/l

5.94

2518

24891

(3015183) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells

113

0.97

0.00

1.2

9.27

8.70

mm/h

0.06

113

(3026250) Tacrolimus [Mass/volume] in Blood

113

0.97

0.00

56.7

39.2

6.41

7.59

ug/l

1.44

100

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

324

0.99

0.00

1.0

1.1

2.32

2.50

eliau/ml

—

139

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

299

1.00

0.00

2.0

2.2

18.56

19.31

mg/l

—

(3017569) Oxygen content in Arterial blood

165

1.03

0.00

1.5

1.7

16.44

16.68

0.16

165

(3020491) Glucose [Moles/volume] in Blood

190

1.00

0.00

1.6

1.9

6.97

6.55

mmol/l

0.37

125

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

127

1.02

0.00

1.0

1.1

—

(40768446) Kidney Pathology biopsy report

110

1.00

0.00

1.5

1.7

—

(3006653) Thiamine [Moles/volume] in Blood

145

1.03

0.00

1.0

1.2

131.93

139.63

nmol/l

0.25

145

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

211

1.00

0.00

1.1

1.0

303.14

289.85

mg/l

0.31

190

(37021550) Renin [Units/volume] in Plasma --upright

0.94

0.00

1.2

1.3

24.12

58.92

mu/l

—

(3001218) Citrate [Mass/time] in 24 hour Urine

0.00

-0.00

0.0

1.5

—

375.75

—

(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma

0.00

-0.00

0.0

1.0

—

1.67

—

(3004347) Hepatitis D virus Ab [Presence] in Serum

0.00

-0.00

0.0

1.0

—

(3017986) Aspergillus versicolor IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3013637) Mi-2 Ab [Presence] in Serum

0.95

-0.00

1.0

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

0.91

-0.00

2.4

1.3

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

0.88

-0.00

1.0

1.2

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

0.92

-0.00

1.8

1.2

39.64

39.89

g/l

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

0.00

-0.00

0.0

2.0

—

(42528595) U1 small nuclear ribonucleoprotein 70kD Ab [Presence] in Serum by Line blot

0.00

-0.00

0.0

1.0

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

0.00

-0.00

0.0

1.0

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(42528596) U1 small nuclear ribonucleoprotein A Ab [Presence] in Serum by Line blot

0.00

-0.00

0.0

1.0

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

0.95

-0.00

1.0

—

(37208534) Antinuclear antibody arbitrary concentration in serum

1.00

-0.00

1.0

—

(40763641) Cell count and Differential panel - Peritoneal dialysis fluid

0.00

-0.00

0.0

2.2

—

(42528597) U1 small nuclear ribonucleoprotein C Ab [Presence] in Serum by Line blot

0.00

-0.00

0.0

1.0

—

(3002719) Hemoglobin [Mass/volume] in Urine

0.00

-0.00

0.0

1.2

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

0.00

-0.00

0.0

1.3

—

(3027401) Testosterone Free/Testosterone.total in Serum or Plasma

0.00

-0.00

0.0

1.7

—

1.36

—

(3041184) Isoniazid [Presence] in Urine

0.00

-0.00

0.0

1.8

—

(3028714) Urate [Moles/time] in 24 hour Urine

0.00

-0.00

0.0

1.3

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

0.94

-0.00

1.0

1.4

1.16

1.17

mmol/l

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

0.00

-0.00

0.0

2.0

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

0.00

-0.00

0.0

2.0

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

0.00

-0.00

0.0

1.1

—

28.11

—

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

0.00

-0.00

0.0

4.6

—

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

0.00

-0.00

0.0

1.1

—

30.53

—

(3012989) Citrate [Moles/time] in 24 hour Urine

0.00

-0.00

0.0

1.4

—

2.19

—

(42529528) Centromere protein B Ab [Units/volume] in Serum by Line blot

0.85

-0.00

1.0

1.1

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

1.00

-0.00

1.0

1.2

—

(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid

0.00

-0.00

0.0

5.4

—

410.60

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

0.00

-0.00

0.0

1.0

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

0.94

-0.00

1.2

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

0.95

-0.00

1.0

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

0.95

-0.00

1.0

—

(3012920) Ethanol [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

1.9

—

2.15

—

(4133840) Spirometry

0.98

-0.00

1.0

1.1

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

0.00

-0.00

0.0

1.4

—

2.86

—

Mortality – FinRegistry

↥

This endpoint is excluded (different definition than used in FinnGen).

Relationships between endpoints

↥

Index endpoint: C3_EYE_BRAIN_NEURO_WIDE – Malignant neoplasm of eye, brain and central nervous system, including Hilmo

GWS hits: 5

This endpoint is excluded (different definition than used in FinnGen).

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Malignant neoplasm of eye, brain and central nervous system, including Hilmo

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints